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ABSTRACT
Staphylococcal enterotoxin B (SEB) is a highly potent CDC select agent that can
trigger acute lung injury (ALI) via robust T cell proliferation and differentiation, and
massive cytokine and chemokine release. Δ9-Tetrahydrocannabinol (THC) is a
psychoactive ingredient found in Cannabis sativa. In the current study, we investigated the
effects of treatment with THC on SEB-induced acute lung injury. To this end, acute lung
injury was induced by a dual dose of SEB in C3H/HeJ mice, which were then treated with
vehicle or THC. THC-treatment led to survival of all the SEB-administered mice when
compared to vehicle-treated. This corroborated with THC-induced decrease in the T
lymphocyte cells in the lungs and increase in the number of myeloid-derived suppressor
cells and Treg. In addition, THC induced a significant decrease in the proinflammatory
cytokines and chemokines in BALF and serum, In order to determine the epigenetic
mechanisms underlying THC-induced beneficial effects, we performed high-throughput
microRNA (miR) microarrays with lung mononuclear cells (MNC) from vehicle and THCtreated SEB-administered mice. Our data showed dysregulation in the expression of
several miRs in these groups. Transcriptome array analysis showed THC induced the
dysregulation of several genes in the epithelial cells and MNC from ALI mice, and some
of dysregulated genes were particularly related to antimicrobial enzymes and peptides,
tight junction proteins and mucins. Pyrosequencing analysis discovered that THC
dramatically altered microbiota in the lung, colon and blood of ALI mice. Furthermore,
beneficial bacterial species such as Ruminococcus gnavus could produce beneficial short-
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chain fatty acids such as propionic acid, butyric acid and acetic acid. Also, we found that
treatment of mice with THC after SEB injection led to attenuation of SEB-induced lung
inflammation through induction of immune cell apoptosis and suppression of T cell
proliferation. Interestingly, single cell RNA sequencing from lungs showed that THC
treatment induced pro-apoptotic genes. In addition, metabolomics analysis revealed
elevated concentrations of apoptosis-related amino acids propionyl L- carnitine. Moreover,
metabolic assays in SEB-activated T cells demonstrated that THC promotes a shift from
dependency on glucose oxidation to fatty acid oxidation. Collectively, this study
demonstrates that THC treatment alleviates SEB-induced ALI.
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CHAPTER 1
INTRODUCTION
1.1 Δ⁹-tetrahydrocannabinol (THC)
Δ⁹-tetrahydrocannabinol (THC) is extracted from the Cannabis sativa plant,
commonly known as marijuana, which has 113 cannabinoids (1). THC is the psychoactive
ingredient of Cannabis and is used as a recreational drug or therapeutic. THC was isolated
and its structure elucidated by Raphael Mechoulam in 1964 (2). THC belongs to the
cannabinoid system which includes cannabinoid receptors, endogenous ligands, as well as
phytocannabinoids. The discovery of the cannabinoid system including endocannabinoids
(anandamide, AEA, and 2-arachydonoylglycerol, 2-AG) and exogenous ligands for the
cannabinoid receptors has had a major impact on therapy after extraction of different
compounds from marijuana. THC mainly acts through the classical receptors, cannabinoid
receptor 1 (CB1) and cannabinoid receptor 2 (CB2), which are members of the superfamily
of G-protein-coupled receptors (3).
THC discovery led to the generation of a variety of synthetic cannabinoids with similar
or distinct structures to phytocannabinoids. This eventually led to the identification and
successful cloning of the CB1 in 1990 (4), followed by mouse specific isolation and
expression of CB1 receptor in 1997 by Abood et al. (5). The CB1 receptor has been
demonstrated in both CNS and in certain peripheral tissue (6). CB2 has 44% sequence
similarity with CB1 receptor.
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It was discovered and cloned by Shire et al. in 1996, specifically in mouse, and is
expressed in the immune system (7). Researchers showed that targeting cannabinoid
receptors may provide a treatment modality to attenuate different diseases, such as
targeting of CB1 receptor can attenuate graft vs host disease by induction of myeloid
derived suppresser cells (8). CB2 receptor has an important therapeutic role for the
modulation of neuroinflammation and attenuation of activated microglia and astrocytes in
Alzheimer's disease (9) . SR141716 (rimonabant) was the first CB1 receptor antagonist to
be described in 1994, followed by SR147778 (surinabant), condensed polycyclic pyrazole
NESS-0327 and indazole derivative O-1248. SR144528 (N-[(1S)-endo-1, 3, 3-trimethyl
bicyclo [2.2.1] heptan-2-yl]-5-(4-chloro-3-methylphenyl)-1-(4-methylbenzyl)-pyrazole-3carboxamide) was the first potent and selective antagonist of CB2 receptor to be discovered
by Rinaldi-Carmona et al.in 1998, followed by 6-Iodoprovadoline (AM630), Indomethacin
morpholinJlamide (BML-190), and JTE-907 (10).
Cannabis has been used medicinally for 6000 years in different cultures to reduce pain
(11). Cannabinoids can be used for the relief of symptoms associated with a variety of
disorders which have not responded to medical treatments. These include pain and
spasticity, severe nausea and vomiting related to cancer chemotherapy, as well as loss of
appetite and body weight in cancer patients and patients with HIV/AIDS (7). More
recently, THC has been used to treat neurotoxicity via its effects as antioxidants. THC has
neuroprotective effects via blocking glutamate neurotoxicity and reactive oxygen species(
ROS )cell death (12). Moreover, THC is approved to treat glaucoma via its effect on ocular
hypotension and neuroprotection (13). THC has been used as a treatment in a variety of
different anti-inflammatory diseases. For example, different clinical trials performed with
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multiple sclerosis patients and orally administered Δ9-THC showed that this treatment can
reduce several signs and symptoms of multiple sclerosis (14, 15). THC can reduce the
inflammatory response induced by hepatic ischemia and ameliorate Con-A-induced
hepatitis (16). THC decreases the release of cytokines, IL-1, IL-6, and IFN, from LPS
stimulated BV-2 microglial cells (17). THC caused bronchodilation in asthmatic patients
by affecting peak expiratory flow rate (18), as well as decreasing proinflammatory
cytokines IL-2, IL-4, IL-5 and IL-13 in murine models of allergic airway disease induced
using ovalbumin (OVA) (19). Recently, THC has been shown to play a major therapeutic
role as an anticancer agent (20). Guzman et al. found that THC can attenuate lung
carcinoma, in vivo and in vitro, by decreasing tumor size and cell growth inhibition (21).
Salazar et al. found that THC can cause autophagy induction and promote apoptotic cancer
cell death through stimulation of ER stress (22).
1.2 Induction of acute lung injury via staphylococcus enterotoxin B
Staphylococcus enterotoxin B (SEB) is a superantigen that causes acute lung
inflammatory lung injury and toxic shock syndrome by massive release of proinflammatory
cytokines,and proliferation of T lymphocytes and natural killer (NK) cells (23). SEB is an
enterotoxin is produce by Staphylococcus aureus which is gram positive bacteria known
to cause food poisoning, diarrhea, vomiting, nausea, and gastrointestinal inflammation
(24). Staphylococcus aureus bacteria can produce six types of superantigen (A-G), with
SEB being the most virulent. Superantigens can activate 30% of T lymphocytes unlike
cognate antigens which are able to activate 0.01% of T lymphocytes via the interaction
between the variable domain of the β chain of the T cell antigen receptor (TCR-Vβ) and
the nonpolymorphic region of major histocompatibility complex (MHC) class II molecules
3

(25). SEB is one of the most important toxins in bioterrorism and is listed as a biologicalwarfare agent by Centers for Disease Control (CDC). Due to this, SEB has been classified
as a category B priority agent (26). Huzella et al. in 2009 detected several methods of
administration of SEB to C3H/HeJ mice to find the most aggressive method and lethal dose
with induction of ALI. They found that a dual dose consisting of administration of SEB
by the intranasal (i.n.) route at a concentration of 5 μg per mouse in 25 μl volume followed
two hours later by a second dose of SEB delivered interperitoneally (i.p.) at a concentration
of 2 μg per mouse in a 100 μl volume caused C3H mice to die after 72 hours, with massive
release of MCP-1 and IL-2 proinflammatory cytokines (27). Cytokines are released in large
amounts, causing the symptoms of toxic shock syndrome (28). Rao et al. found that miR155 as a major effector in SEB-mediated lung inflammation due to increase in SOCs1 and
eventually increase in IFN-ɣ cytokine (29). Saeed et al. found that SEB administration via
intranasal route would cause vascular leak, massive infiltration of lymphocytes, and cell
death in the endothelial cells of the terminal vessels of the lung when it induces acute lung
injury (30).
SEB is known to produce excessive amounts of Th1 cytokines, including IL-2, IFNgamma and TNF, leading to toxic shock (31). SEB-induced Acute Liver Injury caused an
increase in AST levels, necrotic lesions in liver parenchyma, number of immune cells
consisting of CD3+, CD4+ or CD8+ T cells, and NK1.1 cells (16, 32, 33). ALI is a
condition that is characterized by acute severe hypoxia with bilateral pulmonary infiltrates
as observed by chest radiograph, a PaO2/FiO2 ≤300, and pulmonary artery wedge pressure
(PAWP) ≤18 (34). ALI causes histopathological damage to the lung which is represented
by sloughing of both the bronchial and alveolar epithelial cells, excessive neutrophil
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migration, and alveolar macrophages secreting cytokines, interleukin (IL)-1, IL-6, IL-8,
and tumor necrosis factor (TNF)-α, fibroblastic proliferation in alveolar septa as well as
alveolar edema (27, 35) ALI has a high incidence of 78.9 per 100,000 person-years (36).
ALI is a syndrome of acute respiratory failure with a high incidence of morbidity and
mortality (37). The incidence and mortality of acute lung injury increases with age (36).
Three of ten world-wide causes of death are related to respiratory system diseases, such as
chronic obstructive pulmonary disease, lung with trachea/bronchus related cancers, and
lower respiratory infections, all which cause a mortality rate of about 36-44% (38). Kallet
et al. found different etiologies of ALI starting with high percentage in toxic inhalation,
aspiration and pneumonia, and then sepsis and trauma (39). Blood transfusion can also
cause ALI, which was reported in 1951 (40). Recent method of of ALI is supportive
treatment of patients, which is associated with improved ventilator management.
Investigations with numerous pharmacotherapy regimens has been used to decrease
mortality of ALI since 1987, but there is no evidence of positive advantage of these trials
when compared to using glucocorticoid, surfactant, liposomal PGE, inhalation of nitric
oxide, and ketoconazole (41-45).
1.3 Microbiome
Microbiota, in general, has a great impact on host health, immunity, and production
of short chain fatty acids (SCFA) (46). The regular intake of beneficial microorganisms (or
probiotics) is an extensively studied approach for improving the health benefits associated
with commensal microorganisms colonizing the gastrointestinal tract (GIT) of the healthy
host. Different studies have shown that the microbiota plays an important role in both
health and disease status and can exert its influences on various body tissues directly (47,
5

48). The probiotic strains used for human consumption must be of human origin, nonpathogenic and survive gastrointestinal transit in order to confer health benefits on the host
and lead to modulation of the host’s immune response (49). Dietary habits may induce
dysbiosis, which is characterized by an increased percentage of intestinal Gram-negative
bacteria. Gram-negative such as Proteobacteria are a transplantable phylum that accelerates
many disease conditions (50).
The fermentation of non-digestible dietary fiber/carbohydrate results in the production
of SCFAs like acetate, propionate, and butyrate which have significant positive effects on
intestinal epithelial cell function, including maintenance of metabolism, proliferation,
differentiation and promoting low pH (~5) of the gut environment, and favoring beneficial
microbes with a concomitant reduction in pathogenic bacterial growth and viability (51).
SCFAs have been shown to play a positive role in some diseases, but their relation to
microbial dysbiosis is poorly examined in ALI. The use of sequencing technology to
generate large numbers of 16S rDNA sequence tags has been shown to reveal unexplored
aspects and considered the gold standard for phylogenetic studies of microbial
communities (52). With this advanced technology, bacterial species within the human
body that cannot be cultured with standard medical microbiological media have been
discovered. Additionally, knowing the crucial role of microbiome in lung disease was the
main idea of many researchers addressing cystic fibrosis, asthma and allergic airway
disease, chronic obstructive pulmonary disease , idiopathic interstitial pneumonia, and
mechanical ventilation (53-57). The fact that the lung is not sterile tissue has been known
since the 1900s. Programmed death ligand1 (PD-L1) may play a crucial role in the
induction of tolerance against allergens in neonatal naive mice (58). Murine lung
6

microbiome is dominated by variety of phyla which are Proteobacteria, Firmicutes,
Actinobacteria, Bacteriodies and Cyanobacteria (59).
1.4 MicroRNA
microRNA (miRNA/miR) represent a class of small, 22 nucleotide-long, noncoding
RNA molecules (60). The major function of miRNA is posttranscriptional regulation of
protein expression. miRNA is able to control multiple gene function, thus control
regulation of different protein expression (61).
Biogenesis of miRNA is classified into canonical and non-canonical pathways (62)
which can be illustrated by few steps. miRNA genes are transcribed by RNA polymerase
ΙΙ or ΙΙΙ, known as primary microRNA (pri-miRNA), which is then cleaved by Drosha to
become what is called pre-microRNA (pre-miRNA). Pre-miRNA translocate

into

cytoplasm by Exportin5, where it is cleaved by Dicer1 to yield an important miRNA duplex
liberated to mature miRNA by Ago2, TRBP, PACT and Dicer (63).
Many studies demonstrated that miRNA bind to the complementary sequences at
3’UTR of the target mRNA, which leds to silencing of target mRNA. miRNA are involved
in a variety of biological processes, different diseases, cancer, and the immune system (64,
65). Furthermore, miRNA are involved in T cell activation and development. For instance,
miR-181a is negatively regulated in cytotoxic T cells (CD8+) (66). miR-150 is highly
expressed in mature T cells (67). miR may also play an important role in T cell regulation,
as overexpression of miR-34a suppresses TCR-mediated T cell activation like CD4 and
CD8 (68, 69).
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1.5 Metabolomes
Metabolome refers to studies of metabolites (<1.5KDa) found in biological samples
(70).

Metabolic profile was first introduced by Williams in 1940 by using paper

chromatography to check on the metabolites in the urine and saliva (71). Metabolome can
be classified as endogenous or primary, which refers to host organism and exogenous or
secondary, which can be extended to a variety of environmental factors such as disease
process, treatment influence, epigenetics and even can involve microbiome interaction
(72). Host metabolic profile changes can be useful biomarkers to understand the disease
status and treatment interaction (73).
L- carnitine, an amino acid derived from methylation of Methionine and Lysine, helps
in fatty acid transportation across the mitochondrial membranes, by forming acetyl
carnitine and transported by carnitine palmitoyltransferase-1(74). The literature reported
that carnitine and its derivatives can induce apoptosis (75, 76). Carnitine derivatives,
acetyl-L-carntine(ALC), propionayl-L-carnitine(PLC) and isovaleryl-l-carnitine have
positive impacts during clinic applications of different disease conditions (77). Orlandi et
al. found that propionyl-L-carnitine (PLC) can increase smooth muscle cell apoptotic rate
by increasing caspase-3 cleavage (78). The same group added that the apoptosis is due to
the intrinsic pathway by activation of the Bax gene (79). The literature reported that fatty
acid β-oxidation enhanced production of a large amount of reactive oxygen species (ROS)
(80), which can activate the apoptotic pathway (81, 82). Additionally, other literature found
that carnitine causes autophagy through activation of peroxisome proliferator-activated
receptor γ (PPARγ) (83).
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CHAPTER II
ADMINISTRATION OF Δ9-TETRAHYDROCANNABINOL (THC)
POST-STAPHYLOCOCCAL ENTEROTOXIN B EXPOSURE
PROTECTS MICE FROM ACUTE LUNG INJURY AND TOXICITY
2.1 Abstract
Acute Lung Injury is a life-threatening complication that can ensue following
Staphylococcus aureus infection. The enterotoxin produced by these bacteria (SEB) acts
as a superantigen thereby activating a large proportion of T cells leading to cytokine storm
and severe lung injury. Δ9-Tetrahydrocannabinol (THC), a psychoactive ingredient found
in Cannabis sativa, has been shown to act as a potent anti-inflammatory agent. In the
current study, we investigated the effect of THC treatment on SEB-induced ALI in mice.
While exposure to SEB resulted in acute mortality, treatment with THC led to 100%
survival of mice. THC treatment significantly suppressed the inflammatory cytokines,
IFN-γ and TNF-α. Additionally, THC elevated the induction of regulatory T cells (Tregs)
and their associated cytokines, IL-10 and TGF-β. Moreover, THC caused induction of
Myeloid-Derived Suppressor Cells (MDSCs). THC acted through CB2 receptor as
pharmacological inhibitor of CB2 receptors blocked the anti-inflammatory effects. THCtreated mice showed significant alterations in the expression of miRNA (miRs) in the lunginfiltrated mononuclear cells (MNCs). Specifically, THC caused downregulation of let7a5p which targeted SOCS1 and downregulation of miR-34-5p which caused increased
expression of FoxP3, NOS1 and CSF1R. Together, these data suggested that THC-
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mediated alterations in miR expression in the lungs may play a critical role in the induction
of immunosuppressive Tregs and MDSCs as well as suppression of inflammatory
cytokines leading to attenuation of SEB-mediated lung injury.
2.2 Introduction
Acute lung injury and its more severe form, the acute respiratory distress syndrome
(ARDS), are caused by a myriad of etiologies such as toxic inhalation, lung contusion,
pancreatitis, pneumonia, sepsis and trauma (85). Incidence of ALI in USA is 78.9 per
100,000 persons/year and the mortality rate is 38.5% (36, 86) The ALI incidence increases
with age, being more robust and serious in older people (36). ALI is also triggered by
Staphylococcus aureus and its enterotoxin, SEB. ALI is a life-threatening complication of
infection especially caused by methicillin-resistant Staphylococcus aureus (CA-MRSA).
SEB acts as a super-antigen by activating a large proportion of T cells expressing certain
V𝛽-specific T cell receptors. Such an activation leads to release of massive amounts of
cytokines (87) and consequent injury to various organs, including the lungs.

ARDS

remains difficult to treat and thus far, no pharmacological protocol is effective in modifying
the course of this clinical disorder leading to significant morbidity and mortality (86, 88) .
Thus, understanding the mechanisms and developing new treatment modalities against
ALI/ARDS is timely and critical.
Delta-9-Tetrahydrocannabinol (THC) is one of at least 113 cannabinoids identified in
cannabis plant. THC is the principal psychoactive constituent of cannabis. THC acts as a
ligand for two receptors, CB1 and CB2. While its psychoactive properties are attributed
to its ability to activate CB1 expressed in the CNS, because CB2 receptors are primarily
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expressed on immune cells, THC also exerts significant immunosuppressive activity.
There is growing evidence suggesting that THC can suppress inflammation though
activation of CB2 through multiple pathways. These include: a) Switch from Th1 to Th2
(89), b) differentiation of Tregs (16), and c) induction of Myeloid-derived Suppressor Cells
(MDSCs) (90). d) Induction of apoptosis in activated T cells and dendritic cells (91, 92).
In recent years, microRNAs (miRs) have been focus of many studies in the regulation
of genes expression (93). miRs are a class of small non-coding RNAs roughly 20-22
nucleotides in length with extensive secondary structure (94). miRs regulate gene
expression by either directly binding to a specific sequences located at 3’UTR regions of
the genes or degrading messenger RNAs (95). Several studies from our lab have shown a
role for miRs in the regulation of inflammatory genes in various diseases models (96-99).
In a previous study we noted that THC treatment attenuated SEB-mediated lung injury and
that it was associated with downregulation of miRNA-18a, which targeted Pten
(phosphatase and tensin homologue), an inhibitor of the PI3K/Akt signaling pathway
(100).
In the current study, we investigated if THC would induce anti-inflammatory Tregs
and MDSCs in mice exposed to SEB and if their induction was regulated by miR. Our data
demonstrated that THC decreased the expression of two key miRs, let7a-5p and miR-345p which targeted the expression of several signaling molecules that targeted the induction
or functions of Tregs and MDSCs.
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2.3 Materials and methods
2.3.1 Mice:
Female adult C3H/HeJ mice were purchased from The Jackson laboratory. All the
mice were housed in a pathogen-free conditions animal facility of University of South
Carolina School of Medicine. The facility is accredited by AALAC. All experiments using
mice were performed under protocols approved by the Institutional Animal Care and Use
Committee (IACUC) of USC.
2.3.2 Chemicals and Regents:
Staphylococcus enterotoxin B (SEB) was purchased from Toxin Technologies
(Sarasota, FL, USA). Delta-9-Tetrahydrocannabinol (THC) was procured from (NIH
National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA). The
following reagents (culture medium reagents: RPMI 1640, L-Glutamine, PenicillinStreptomycin, HEPES, FBS, and PBS) were purchased from Invitrogen Life Technologies
(Carlsbad, CA). We purchased the following antibodies: Phycoerthyrin (PE)-conjugated
anti-CD4 (clone: GK 1.5), BV510-conjugated anti-Gr-1 (RB6-8c5), Alexa floura700conjugated anti-CD11b (clone: M1/70), Alexa Flour 488-conjugated anti-Foxp3 (clone
MF-14), and Foxp3 Fix/Perm buffer from Biolegend (San Diego, CA, USA). Fc Block
reagent was purchased from BD Pharmingen (Carlsbad, CA). True-Nuclear™
Transcription Factor Buffer Set was purchased from BioLegend. RNeasy and miRNAeasy
Mini kits, miScript primer assays kit, and miScript SYBR Green PCR kit were purchased
from QIAGEN (QIAGEN, Valencia, CA). iScript and miScript cDNA synthesis kits were
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purchased from Bio-Rad (Madison, WI) and Epicentre’s PCR premix F and Platinum Taq
DNA Polymerase kits were purchased from Invitrogen Life Technologies (Carlsbad, CA).
CB2 receptor antagonist SR144528 (SR144) was purchased from TOCRIS
(Minneapolis, MN, USA) and was reconstituted and stored according to manufacturer’s
recommendations. ELISA kits for IL-4, IL-10, and TGF-β (ELISA MAXTM Standard SET
Mouse) were purchased from Biolegend.
2.3.3 Exposure of mice with SEB and THC treatments:
SEB was delivered as a ‘Dual Dose’ as described previously (27). This approach
causes 100% mortality with low concentrations of SEB and triggers ALI in C3H/HeJ mice.
In brief, SEB dissolved in sterile PBS was administered first by the intranasal (i.n.) route
at a concentration of 5 μg per mouse in 25 μl volume. Two hours later, a second dose of
SEB was delivered (i.p.) at a concentration of 2 μg per mouse in a 100 μl volume. THC
was given in 3 doses: First dose of vehicle or THC was given at 20mg/kg, i.p immediately
after first SEB exposure. Second and third doses of THC were given i.p at 10mg/kg after
24 and 48 hours after the first dose of THC. SEB‐exposed mice displayed signs of lethargy,
hunching, ruffled fur and respiratory distress and such mice were euthanized. For survival
studies, mice that were administered with SEB+Veh or SEB+THC, as described above,
were observed for 40 days and any mice showing distress were euthanized. To study the
immune response and miR expression, mice were euthanized 72 hrs after SEB+Veh or
SEB+THC exposure and lung mononuclear cells (MNCs) and Bronchoalveolar Lavage
Fluid (BALF) were collected as previously described (101).
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2.3.4 Evaluation of lung functions:
To understand the effect of SEB and THC treatments, lung functions were measured
using whole-body plethysmography (Buxco, Troy, NY, USA). Each mouse was restrained
in a two-chamber plethysmographic tube and was allowed to acclimatize as previously
described (101). The lung function was calculated as the Specific Airway Resistance
(sRaw), Specific Airway Conductance (sGaw), delay time (dT), and Peak expiratory flow
(PEF).
2.3.5 Analysis of lung infiltrated mononuclear cells (MNCs):
We analyzed lung infiltrated mononuclear cells (MNCs) post-SEB exposure and THC
treatments. In brief, mice were euthanized 72 hours post-SEB exposure. The lungs from
SEB + vehicle and SEB + THC groups were first perfused with heparin-containing PBS,
then harvested and homogenized using Stomacher® 80 Biomaster blenders from Seward
(Davie, FL, USA) in 10 mL of sterile PBS. Cells, after washing with cold PBS twice, were
layered carefully onto Ficoll-Histopaque®-1077 (Sigma-Aldrich, St Louis, MO, USA) at
a 1:1 ratio. Mononuclear cells were separated by density gradient centrifugation as
described previously (102) and enumerated by Trypan blue exclusion. To determine the
phenotypical characteristics of the infiltrating cells, mononuclear cells were stained with
the fluorescent conjugated antibodies Phycoerthyrin (PE)-conjugated anti-CD4 (clone: GK
1.5), (BV510)-conjugated anti-Gr-1 (RB6-8c5), (Alexa floura700)-conjugated anti-CD11b
(clone: M1/70) from Biolegend (San Diego, CA, USA). Intracellular staining of Foxp3 was
carried out using Biolegend's Foxp3 Fix/Perm buffer set following manufacturer's
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instructions and using anti-foxp3 Alexa floura 488 (clone MF-14) from Biolegend. The
stained cells were analyzed using BD Celesta flow Cytometry and DIVA software.
2.3.6 Analysis of Cytokines in BALF:
To assess cytokines post-SEB exposure and treatment with vehicle or THC, we
analyzed BALF Broncho Alveolar Lavage Fluid (BALF) from lungs of mice. BALF was
obtained by binding the trachea with a suture and excising the lung along with the trachea
as described previously (102). In brief, sterile, ice-cold PBS was injected through the
trachea to aspirate the fluid. The collected BALF was centrifuged to obtain the supernatants
containing cytokines. ELISA was performed using ELISA MAX™ standard kits from
Biolegend and following the protocol of the company to determine cytokines present in
BALF.
2.3.7 Quantitative Real-Time (Q-PCR) to determine the expression of FOXP3, IL10,
NOS2, and TGF-βR3:
We performed Q-PCR to determine the expression of FOXP3, IL10, NOS2, and TGFβR3 in lung infiltrated MNCs. To this end, cDNAs were generated using total RNAs
isolated from mice treated with SEB+Veh or SEB+THC. We used SSO Advanced™
SYBR green PCR kit from Bio-Rad (Hercules, CA, USA). The following primers for
FOXP3, IL10, NOS2, and TGF-β were used. The sequences primers used are described in
Table 1.
The following PCR cycles (40 cycles) conditions: 15min at 95°C (initial activation
step), 15s at 94°C (denaturing temperature), 30s at 60°C (annealing temperature), and 30s
at 70°C (extension temperature and fluorescence data collection) were used. Expression of
mRNAs was calculated using NE ¼ 2_DDCt, where Ct is the threshold cycle to detect
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fluorescence. Fold change of mRNA levels was normalized to GAPDH (a house keeping
gene).
2.3.8 miR arrays analyses to evaluate microRNAs profile in lung infiltrated MNCs:
Total RNAs including miRs were isolated from lung infiltrated MNCs harvested from
mice exposed to SEB and treated with vehicle or THC using miRNAeasy kit from Qiagen
and following the protocol of the company (Qiagen). Using Affymetrix miR array
(GCS3000 System, version 4), miRs arrays were performed. Expression (fold change)
profile of over 3000 miRs were obtained from the raw array data and only those miRs that
showed more than 2-fold change were considered for further analysis. The selected miRs
were further analyzed for their targets and alignments using TargetScan, microRNA.org,
and miRWalk and their database, as described (32, 96, 103). Furthermore, selected miRs
were analyzed for their role in various diseases and pathways using Ingenuity pathway
analysis (IPA) software. miRs from various groups were also analyzed for their relationship
using Lucid Chart or Venn diagram.
2.3.9 Transcriptome arrays to analyze gene expression in lung MNCs:
To understand SEB-induced regulation of genes following treatment with THC in lung
infiltrated MNCs, we performed to Transcriptome arrays using GCS3000 Affymtrix
System. In brief, total RNA from purified lung MNCs was isolated using miRAeasy Mini
kit and following the protocol of the company (Qiagen). In brief, single strand cDNAs
were synthesized in a thermal cycler incubating the reaction mix (total RNAs and cDNA
reagents) for 60 min at 25˚C, 60 min at 42˚C, and then at 4˚C. Next, second strand cDNAs
were synthesized from first-stranded cDNAs to generate double-stranded cDNAs.
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Complementary RNAs (cRNAs) were synthesized according to Eberwine method (104)
using T7 RNA polymerase to in vitro transcription (IVT) of second-stranded cDNA into
cRNA by incubating the IVT master mix with second-stranded cDNA for 16 hours at 40˚C.
Magnetic microbeads (Affymetrix, USA) were used to purify the cRNAs. Purified cRNAs
(15 µg) was used to synthesize second cycle of ss-cDNA by the reverse transcription of
cRNA using 2nd-cycle primers. The remaining cRNAs were removed using RNase H.
Microbeads-purified ss-cDNA was fragmented by uracil-DNA glycosylase and using
purinic/pyrimidinic endonuclease 1 at the unnatural dUTP residues to break the DNA
strand. The fragmented ss-cDNAs were then labeled using labeling master mix just before
the hybridization process. Hybridization master mix (contains fragmented and labeled sscDNAs) was first loaded into ClariomD chip (Affymetrix, USA) and then the GeneChip
was incubated in Hybridization Oven 645 (Affymetrix, USA) for 16 hours at 45˚C with
rotation at speed of 60 rpm. Next, GeneChip Hybridization Wash and Stain kit (Affymetrix
– USA) was used to wash and stain the chips containing hybridized ss-cDNA at RT by
using GeneChip Fluidics Station 450 (Affymetrix – USA) for about 2 hours. Once the
staining and washings were done, the chips were scanned using GeneChip Scanner
(Affymetrix, USA) and the obtained raw data was analyzed using Transcriptome analysis
console (TAC) to determine the expression of genes in MNCs.
2.3.10 Real-Time (qRT-PCR) to validate the expression of select miRs and associated
genes:
To validate the expression of select miRs (let-7a-5p and miR-34a-5p) and associated
genes (FoxP3, SOCS1, NOS1, and CSF1R) in lung infiltrating MNCs post exposure to
SEB and treated with vehicle or THC, qRT-PCR assay was performed. In brief, total RNA
including miR from lung infiltrating MNCs was isolated using miRNAeasy kit from
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Qiagen and following the manufacturer's instructions. miScript primer assay kit and
miScript SYBR Green PCR kit from QIAGEN were used and qRT-PCR assay was
performed following the protocol of the company (QIAGEN, Valencia, CA). For qRTPCR, 40 cycles using the following conditions: 15min at 95°C (initial activation step), 15s
at 94°C (denaturing temperature), 30s at 60°C (annealing temperature), and 30s at 70°C
(extension temperature and fluorescence data collection) were used.

Normalized

expression (NE) of miRs was calculated using NE ¼ 2_DDCt, where Ct is the threshold
cycle to detect fluorescence. The data were normalized to miRs against internal control
miR (SNORD96A) and fold change of miRs was calculated against control miR
(SNORD96A). To determine the expression of genes, mRNA levels were normalized to
GAPDH (a house keeping gene). Predicted miRNA‐target gene alignments were
determined with online miRNA database (www.microrna.org). The details of primers used
for miRs (let-7a—5p and miR-34a-5p) and associated genes (Foxp3, SOCS1, NOS1, and
CSF1R) The sequences primers used are described in Table 1.
2.3.11 Transfection of splenocytes with miR-34a:
Splenocytes harvested from naïve C3H/HeJ mice were cultured in complete RPMI
medium supplemented with 10% FBS and 1% penicillin/streptomycin. The cells were
seeded at density of 2X105 cells/well in a 24-well plate and were activated with 1µg/ml
SEB overnight. The following day, SEB-activated cells were transfected using Qiagen
HiPerfect Transfection Reagent and 20nM of miR-34a mimic (syn-mmu-miR-34-5pmimic: 5'-UGGCAGUGUCUUAGCUGGUUGU-3’) or anti-mmu-miR-34-5p-inhibitor
(5'-UGGCAG UGUCUUAGCUGGUUGU-3’) or transfection reagent alone (mock) as
previously described (33). The transfected cells were cultured for 48 hours. The transfected
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cells were then collected and used for total RNAs including miRs isolation. Total RNA
was then used for validation of miR-34a and Foxp3, NOS1, and CSF1R expression.
2.3.12 Statistical analysis:
All statistical analyses were carried out using GraphPad Prism v6 Software (San
Diego, CA, USA). In all the experiments, the number of mice used was 4 per group, unless
otherwise specified. Student's t-test was used to compare the two groups, whereas multiple
comparisons were made using one-way ANOVA, followed by post hoc analysis using
Tukey's method. A p-value of <0.5 was considered statistically significant. Individual in
vitro experiments were performed in triplicate. Each experiment was performed
independently at least three times to test the reproducibility of results. Survival analysis
was carried out using a log-rank.
2.4 Results
2.4.1 THC treatment of mice exposed to staphylococcal Enterotoxin-B (SEB) protects them
from Acute Lung Injury (ALI):
The mice exposed to dual dose of SEB and treated with vehicle (SEB+Veh)
succumbed to death within 72-120 hrs. post-exposure, but 100% of SEB-exposed mice
treated with THC (SEB+THC) survived (Figure 2.1A), consistent with our previous studies
(105). Upon analysis of lung functions using plethysmography, SEB+Veh exposure
caused a significant increase in the specific airway resistance (sRaw) and delay time (dT)
due to the obstruction in the airway, while this effect was reversed in mice treated with
SEB+THC (Figure 2.1B).

Moreover, SEB+Veh-treated mice recorded a significant

decrease in Specific Airway Conductance (sGaw) and Peak expiratory flow (PEF), while
THC treatment led to reversal of these effects (Figure 2.1B). All pulmonary functions listed
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above were also evaluated 40 days post-SEB exposure in the survival group (SEB+THC)
and compared with naïve mice of the same age. The results of pulmonary functions showed
that the survival group had normal pulmonary functional similar to naïve mice (Figure
2.1C).
2.4.2 THC treatment suppresses inflammatory cytokines IFN-γ and TNF-α but promotes
the generation of anti-inflammatory cytokines TGF-β and IL-10 in BALF of mice:
SEB, being a superantigen, is known to cause massive release of cytokines. Therefore,
we examined the generation of key cytokines (IFN-γ, TNF-α, TGF-β IL-10, and M-CSF)
in BALF isolated from mice that were exposed to SEB+Veh or SEB+THC. The data
showed that inflammatory cytokines, IFN-γ and TNF-α were upregulated in mic exposed
to SEB+Veh, when compared to naïve mice (Fig 2.2A-B), but significantly decreased in
mice treated with SEB+THC (Fig 2.2A-B). Upon analysis of anti-inflammatory cytokines
(TGF−β and IL −10), we noted significant decrease in both TGF−β and IL-10 in BALF
of SEB+Veh-exposed mice, when compared to naïve mice (Fig 2.2C and E). However,
THC treatment significantly increased the levels of TGF−𝛽 and IL-10 in BALF of SEBtreated mice (Figure 2.2C-E). We also noted that SEB+Veh-treated group had significantly
lower levels of M-CSF while treatment with THC caused marked increase in M-CSF.
Next, we examined the presence of various immune cell subsets in the lung infiltrating
MNCs. To this end, we stained MNCs with various fluorescein-conjugated anti-mouse
antibodies to detect regulatory T cells (Treg: CD4+/FoxP3+) and Myeloid Derived
Suppressor Cells (MDSCs: CD11b+/Gr-1+ cells) and analyzed using a Flow Cytometer.
These data showed that mice exposed to SEB+THC had significantly more percentages of
Tregs (Figure 2.2F) and MDSCs (Figure 2.2G) in lung infiltrating MNCs, when compared
to SEB+Veh group (Figure 2.2F-G). Data taken together suggested that THC treatment
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promoted the generation of anti-inflammatory cytokines (TGF−𝛽 𝑎𝑛𝑑 𝐼𝐿 −10) and
immunosuppressive cells (Treg and MDSCs) while significantly suppressing the
generation of inflammatory cytokines (IFN-γ and TNF-α).
2.4.3 THC-mediated induction of Treg and MDSCs is CB2-dependent:
Because immune cells express CB2 receptors (106), we next investigated if THC was
acting through CB2. To that end, splenocytes were first activated with SEB and then
treated with CB2 antagonist (SR144528) at a concentration of 50μm or Vehicle, 1 hour
before treating the cells with THC. We observed that the presence of CB2 antagonist
caused decreased THC-mediated induction of Tregs and MDSCs when compared to the
controls (Figure 2.3A). Furthermore, upon examination of expression of several associated
genes (FoxP3, IL-10, NOS1, and TGF- 𝛽R3) by performing qRT-PCR, we observed
significant decrease in their expression in cells treated with CB2 antagonist, when
compared to Vehicle controls (Figure2.3B). Data taken together demonstrated that THC
acts through CB2 receptor in modulating immune cell functions.
2.4.4 THC treatment altered miR profile in lung infiltrated MNCs:
Recent studies from our lab have shown that THC caused dysregulation of miR
expression in mice (107) (99). To investigate the effect of SEB and THC on miR profile
and correlate with Treg and MDSCs induction and suppression of SEB-induce ALI in mice,
we performed miRs arrays using total RNAs including miRs from lung infiltrated MNCs
from mice exposed to SEB and treated with vehicle or THC. There were more than 3103
of miRs that were analyzed by arrays (Figure6.2A). However, there were only 115 miRs
out of 3103 miRs that were dysregulated greater than two-fold in SEB+THC group when
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compared to SEB+Veh-treated MNCs (Figure 2.4A). As shown in Scatter plot (Figure 4B)
and Venn diagram (Figure 2.4C), there were (2988) miRs that showed no change (Figure
4B-C), whereas, 11 miRs were upregulated (Figure 2.4B-C) and 104 miRs were
downregulated (Figure 2.4B-C). Furthermore, upon analysis of 115 dysregulated miRs
using ingenuity pathway analysis (IPA) software, we observed a direct relationship
between various miRs and the target genes including miR-34a-5p and the target genes
FoxP3, IL-10, NOS1, CSF1Rr, and SOCS1, and miR-let-7a-5p that targets SOCS1 and
IFN-γ genes (Figure 2.4D). These data demonstrated that THC-mediated alterations in
miRs may regulate the expression of various genes (FoxP3, IL-10, NOS1, CSF1Rr,
SOCS1, and IFN-γ etc.), which in turn may regulate generation of Treg and MDSCs.
2.4.5 Effect of THC on regulation of genes to identify mechanistic pathways that trigger
SEB-induced ALI in mice:
Next, we examined the altered expression of genes in lung infiltrated MNCs by
performing transcriptome arrays using total RNA isolated from MNCs post-exposure to
SEB and treated with vehicle or THC as described in detail in Materials and Methods. Data
obtained from Transcriptome arrays showed dysregulation of a large number of genes in
MNCs of the two groups (Figure 2.5A). Figure 5A shows Heat map of the dysregulated
genes in SEB+Vehicle and SEB+THC groups. Based on the 2-fold change in the gene
expression, Heat map showed dysregulation of many genes related to cytokines, T cell
proliferation, Xenobiotic toxin, and enzymes in SEB+Vehicle and SEB+THC groups
(Figure 2.5B). Volcano plot analysis also showed dysregulation of a large number of genes
(Figure 2.5C). Upon analysis of dysregulated genes in the two groups using IPA Analysis
software, we observed a strong relationship between miR array and transcriptome array
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data obtained from MNCs. We observed that miR-34a showed relationship with FoxP3,
CSF1R, IRAK4, SOCS1, NOS1, IF135, and ANXA5 (Figure 2.5D).
2.4.6 Validation of selective miRs expression and their target genes in MNCs:
We selected two miRs (miR-let-7a-5p and miR-34a-5p) based on the complementary
binding affinity of miR-let-7a-5p with SOCS1 gene (Fig 6A) and miR-34a-5p with NOS1
(Figure 6B), FoxP3 (Figure 2.6C), and CSF1R (Figure 2.6D). We performed qRT-PCR
using mouse miR-let-7a-5p and miR-34a-5p-specific sets of forward and reverse primers
as described in Materials and Methods. Data obtained from qRT-PCR showed significant
downregulation of both miR-let-7a-5p (Figure 2.6E) and miR34a-5p (Figure 2.6F) in
MNCs of SEB+THC group, when compared to SEB+vehicle group. Next, we also
examined the expression of miR-let-7a-5p target gene NOS1 and miR-34a-5p target genes
(SOCS1, FOxP3, and CSF1R) by performing qRT-PCR as described in Materials and
Methods. There was significant upregulation all these four genes in MNCs of SEB+THC
group, when compared to SEB+Vehicle group (Figures 6G, NOS1; H, SOCS1, I, FoxP3,
and J, CSF1R). These data suggested that THC alters the expression of miRs in MNCs
which may regulate induction and functions of Tregs, MDSCs and cytokine production.
2.4.7 Analysis of miR-34a-5p expression and that of its targeted genes NOS1, FoxP3, and
CSF1R:
To further corroborate the role of miRs, we performed transfection assays to determine
if miR34a-150-5p targeted the expression of NOS1, FoxP3, SOCS1, and CSF1R. In brief,
splenocytes were cultured overnight in the presence of SEB and the following day, the cells
were Mock-transfected or transfected with mature miR-34a-5p or anti-miR-34a-5p
inhibitor. The transfected cells were cultured for 48 hrs and the expression of miR-34a-5p
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(Fig 2.7A) and NOS1, FoxP3, and CSF1R (Fig 2.7B-D) genes was determined by
performing qRT-PCR. The splenocytes transfected with mature miR-34a-5p showed
significantly upregulated expression in these cells (Figure 2.7A). However, transfection of
splenocytes with anti-miR-34a-5p inhibitor showed downregulated expression of miR-34a5p when compared to cells transfected with miR-34a-5p mimic (Fig 2.7A). To further
understand the role of miR-34a-5p, we performed qRT-PCR to determine the expression
of NOS1, FoxP3, and CSF1R genes in the transfected splenocytes (Figure2. 7B-D). The
expression of NOS1, FoxP3, and CSF1R was significantly suppressed in the transfected
splenocytes in the presence of miR-34a-5p mimic (Figure 2.7B-D). However, the
expression of the above genes was significantly increased in the splenocytes in the presence
of anti-miR-34a-5p inhibitor (Figure 2.7B-D). Data obtained from this study showed that
miR-34a-5p is directly involved in the regulation of NOS1, FoxP3, and CSF1R.
2.5 Discussion
Staphylococcus enterotoxin B (SEB) is produced by gram-positive bacteria,
Staphylococcus aureus, which is ubiquitous that adversely affects about one-third of the
general population worldwide. It is responsible for staphylococcal food poisoning in
humans and has been produced by some countries as a biological weapon (108) (109)
(110). SEB acts as a super antigen as it activates a large number of T cells such as those
expressing Vβ8, triggering cytokine storm, acute toxic shock, and multi-organ failure
leading to mortality (111) (112). SEB is also known to cause ALI/ARDS. Previous studies
from our lab have shown that dual dose administration of minute doses of SEB into
C3H/HeJ mice caused severe lung injury and mortality through the expansion of T
lymphocytes and massive release of pro-inflammatory cytokines such as IFN-γ while
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treatment with THC rescued these mice from SEB-mediated toxicity (100). In the previous
study, we injected two doses of THC (20mg/kg) prior to SEB injection and one dose after
SEB exposure (100). In the current study, we tested to see if treatment with THC after
exposure to SEB was also effective and we noted that it was indeed able to reverse the
toxicity of SEB thereby providing translational significance. While in the previous study,
we noted that SEB induced miRNA-18a, which targeted Pten (phosphatase and tensin
homologue), an inhibitor of the PI3K/Akt signaling pathway, thereby suppressing the
induction of Tregs, THC treatment inhibited miRNA-18a thereby reversing the effects of
SEB (100). Because THC is known to trigger multiple pathways to suppress inflammation,
we

investigated

additional

mechanisms

involving

miRs

that

may

target

immunosuppressive cells such as MDSCs. Our results showed that THC induced both
MDSCs and Tregs and that their induction correlated with down-regulation of miR-let-715p and miR-34a-5p, which targeted key molecules such as NOS1, FoxP3, CSF1R, and
SOCS1.
In the current study, we observed that THC suppressed SEB-induced inflammation
and improved the pulmonary functions of the lung which was associated with activation
and recruitment of Tregs and MDSCs to the site of inflammation (Figure 1A). Moreover,
THC-mediated effect on ALI was regulated through CB2 receptor, inasmuch as blocking
CB2 with a CB2 antagonist (SR 144) decreased the ability of THC to induce MDSCs and
Treg as well anti-inflammatory cytokines (Figure 2.3A-B). THC has been shown to
mediate potent anti-inflammatory properties through multiple pathways which include
recruitment of MDSCs and regulatory T cells (8, 113, 114)Previous studies from our lab
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showed that the anti-inflammatory properties of THC was mediated at least in part through
induction of MDSCs and a significant increase in GCSF which recruits MDSCs (16).
Several studies from our lab and others have characterized MDSCs as potent
immunosuppressive cells (115, 116) MDSCs may also be induced at sites of inflammation
and may prevent tissue injury by downregulating inflammatory T cell responses (117).
Cauley et al. showed that repeated systemic administration of staphylococcal enterotoxin
A (SEB) led to induction of tolerance via accumulation of MDSCs in the spleen (118). We
have recently also shown that THC attenuated chronic colitis in IL-10 knockout mice
through MDSCs induction (119). Rieder et al. demonstrated that THC-induced
immunosuppressive MDSCs play a critical role in suppressing lung-injury (102). There
are studies that have shown the role of MDSCs in the suppression of pro-inflammatory
cytokines and other mediators such as G-CSF, GM-CSF, IL-1β, IL-12, and IFN-γ (115).
Similar to MDSCs, the role of Tregs in suppressing inflammation has been well
established. In this study, we observed that THC promoted generation of Tregs (Figures
2.2F) and associated cytokines such as IL-10 (Figures 2D) and TGF-β (Figures 2C) in lung
infiltrating MNCs. These data are consistent with previous studies showing that THCmediated induction of Tregs attenuates ConA-induced liver injury in mice (16). In another
study involving colitis, it was shown that activation of CB2 by JTE907 promotes the
differentiation of Th0 cells into the Treg cell phenotype, which was characterized by the
expression of FoxP3, TGF-β and IL-10 (120).

Tregs are known to mediate their

immunosuppressive functions through release of ant-inflammatory cytokines, such as IL10 and TGF-β (121). In this study, we also observed upregulated expression of IL-10 in
lung infiltrating MNCs (Figure 2.2D).
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Many studies have been shown that miRs play a major role in the regulation of gene
expression and the immune responses (122), including autoimmunity and inflammation
(123). We and others have shown previously that miRs play a critical role in promoting
anti-inflammatory functions and immune suppression (123)(124)(125)(32)(126). In the
current study, therefore, we investigated if treatment with THC following SEB injection
would alter the expression of miRs in lung immune cells. In this study, we observed that
THC caused altered expression of a large number of miRs in lung infiltrating MNCs of
mice exposed to SEB, when compared to mice treated with vehicle (Figure 2.4D). Upon
pathway analysis of miRs using IPA, we identified two downregulated miRs (miR-let-715p and miR-34a-5p) in MNCs that may play significant role in THC-induced immune
suppression. MiR-let-7a-5p showed strong binding affinity with complementary sequences
of 3′ UTR regions of SOCS1 gene whereas miR-34a-5p showed strong binding affinity
with NOS1, FoxP3, and CSF1R genes. Because THC downregulated the expression of
miR-let-7a-5p and miR-34a-5p, these data suggested that this effect was responsible for
increased expression of SOCS1, NOS1, FoxP3, and CAF1R in the MNCs. The role of miR34a-5p to regulate the expression of NOS1, FoxP3, and CSF1R was further confirmed by
performing transfection experiments and qRT-PCR (Figure 2.7). There was significant
downregulation of NOS1, FoxP3, and CSF1R expression in splenocytes that were
transfected with miR-34a-5p mimic while the expression of NOS1, FoxP3, and CSF1R
was significantly upregulated in splenic cells that were transfected with anti-miR-34a-5p
inhibitor. NOS1 is a neuronal isozyme known to promote inflammation. However, NOS1
can metabolize arginine to produce nitric oxide. Arginine is an essential metabolite for T
cells and thus, NOS1 can deprive T cells of arginine thereby suppressing proinflammatory
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T cells (127). In fact, MDSCs use such a mechanism involving direct deprivation of
arginine. MDSCs have been shown to express CSFR1 (128), also known as macrophage
colony-stimulating factor receptor (M-CSFR).

In addition, activation of CSFR1 is

involved in the differentiation of immunosuppressive macrophages (129).
FoxP3 is a master regulator of the development and functions of Tregs (130). Our
data that FoxP3 is induced by THC in SEB model is consistent with previously published
studies in models such as Graft-vs-Host disease and experimental model of Multiple
Sclerosis (99, 131) . In the previous study involving treatment with THC prior to SEB
injection, we found that THC downregulated miRNA-18a, which targeted Pten, an
inhibitor of the PI3K/Akt signalling pathway, thereby inducing T-regulatory cells (100).
In the current study involving post-SEB treatment with THC, we identified yet another
miR (miR-34a-5p) that may target FoxP3 directly and thereby lead to induction of Tregs.
SOCS1 is a negative regulator of cytokine signaling. Thus, it suppresses the induction of
inflammatory cytokines. In addition, SOCS1 maintains the stability of Tregs and prevents
their plasticity to differentiate into inflammatory Th17 and Th1 cells when exposed to
inflammatory cytokines (132). Thus, the induction of NOS1, FoxP3, CSF1R, and SOCS1
by THC following down-regulation of miR-34a-5p and miR-let-7a-5p, may lead to
activation of a wide array of immunosuppressive pathways involving cytokines, Tregs,
MDSCs and macrophages.
In summary, the current study suggests that treatment of mice with THC post-SEB
challenge protects mice from SEB-mediated toxicity by inhibiting inflammation and ALI
through the modulation of miRs. Because SEB is a super antigen that drives cytokine
storm, our studies suggest that THC is a potent anti-inflammatory agent that has the
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potential to be used as a therapeutic modality to treat SEB-induced ALI. This study also
suggests that THC may mediate its effects through downregulating the expression of miRlet-7a-5p and miR-34a-5p that target the expression of SOCS1, NOS1, FoxP3, and CSF1R
and consequently trigger immunosuppressive MDSCs and Treg as well as directly suppress
inflammatory cytokines, leading to attenuation of SEB-induced ALI in mice.

Figure 2.1: THC attenuates SEB-induced acute lung injury (ALI) in mice. SEB was
administered first by the intranasal (i.n.) route followed by a second dose of SEB was
delivered (i.p.) as described in Methods. Mice were then treated with vehicle (SEB+Veh)
or THC (SEB+THC). A: Showing survival of mice 40 days post lethal dual-dose exposure
to SEB and treated with THC or Vehicle. B-C: Pulmonary performance (sRaw, specific
resistance airway; sGaw, specific conductance airway; PEF, peak of expiratory flow; dT,
delayed time of translocation of air from thoracic to nasal canal and verse versa) evaluation
of experimental mice by Whole-body non-invasive plethysmograph Buxco 72 hours postSEB-induced ALI. Statistical significance is depicted as * P<0.05, ** P<0.01, *** P<0.001
between the groups.
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Figure 2.2: THC suppresses inflammatory cytokines and induces Tregs and MDSCs. Mice
were treated with SEB+Veh or SEB+THC as described in Fig 2.1 legend. Panels A-E
depicts various cytokines detected in BALF using ELISA. F: Lung MNCs stained for
CD4+/FoxP3+ Tregs showing a representative experiment using flow cytometry. Vertical
bars show data from 4 mice with Mean+/-SEM. G: Staining lung MNCs for expression
of CD11b+ and Gr-1+ MDSCs, showing a representative experiment using flow cytometry.
Vertical bars show data from 4 mice with Mean+/-SEM. Statistical significances are
depicted as * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001 between the groups.
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Figure 2.3: THC promotes the generation of Tregs and MDSCs through CB2 receptor
activation. Spleen cells were cultured with SEB+THC in the presence of vehicle or CB2
antagonist, SR-144. A: shows in vitro generation of Tregs and MDSCs in the presence of
vehicle or CB2 antagonist (SR144). Vertical bars show data from 4 mice with Mean+/SEM. B: Expression of genes (FoxP3, IL-10, NOS2, TGF-βR3) using RT-PCR in
SEB+THC-activated splenocytes cultured in the presence of vehicle or CB2 antagonist
(SR144). Statistical significances are depicted as * P<0.05, ** P<0.01, *** P<0.001, ****
P<0.0001 between the groups.
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Figure 2.4: THC alters miR expression in lung infiltrated MNCs exposed to SEB. Mice
were treated with SEB+Veh or SEB+THC as described in Fig 1 legend. MNCs from the
lungs were isolated and screened for miR expression as described in Methods. A: Heat
map of total miRs in SEB+vehicle and SEB+THC groups. B: Up- and down-regulated
miRs post calculation of total miRs (linear miRs). C: Venn diagram of upregulated or
downregulated or no change in miRs expression. E: Shows pathways and relationship
between miRs and genes post IPA analysis of dysregulated miRs.
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Figure 2.5: THC treatment affects transcriptional profiles of gene expression in lung
infiltrated MNCs of mice exposed to SEB. Mice were treated with SEB+Veh or SEB+THC
as described in Fig 1 legend. MNCs from the lungs were isolated and subjected to
transcriptional analysis as described in Methods. A: Heat map of total genes in SEB+veh
and SEB+THC groups. B: Heat map showing genes associated with cytokines, T cells
proliferation, xenobiotic toxin, and in enzymes in SEB+veh vs SEB+THC groups. C: Upand down-regulated genes post calculation of total genes (linear). D: Shows relationship
between genes and miRs post IPA analysis of dysregulated genes.
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Figure 2.6: Validation of selective miRs and targeted genes: Mice were treated with
SEB+Veh or SEB+THC as described in Fig 1 legend. MNCs from the lungs were isolated
and screened for miR expression and inflammatory markers by quantitative RT-PCR. A:
Showing binding affinity between miR-let-7a-5p and SOCS1. B-D: Showing binding
affinity between miR-34a-5p and NOS1, FoxP3 and CSF1R. E-F: Expression of miR-let7a-5p and miR-34a-5p. G-J Expression of targeted genes NOS1, SOCS1, FoxP3 (I), and
CSF1R (J) in lung infiltrated MNCs. Statistical significances are depicted as
*
P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001 between the compared groups.
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Figure 2.7: Validation of genes targeted by miR-34a-5p. Splenocytes harvested from naïve
C3H/HeJ mice were cultured and activated with SEB overnight followed by transfection
with mock, mimic or inhibitor of miR-34a-5p. RT-PCR was used to detect the levels of
targeted genes. A: miR-34a-5p expression with mock, mimic or miR-34-5p inhibitor. B-D:
Expression of FoxP3 (B), NOS1 (C), and CSF1R (D) in the presence of mock, mimic or
miR-34-5p inhibitor. Data presented as vertical bars represent Mean+/– SEM of triplicates.
Statistical significances are depicted as * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001
between the compared groups.
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CHAPTER III
PROTECTIVE EFFECTS OF Δ9-TETRAHYDROCANNABINOL
(THC) AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB)INDUCED ACUTE LUNG INJURY IS MEDIATED BY MODULATION
OF MICROBIOTA
3.1 Abstract
SEB is one of the most potent bacterial superantigens that exert profound toxic effects
by inducing cytokine storm. When SEB is administered in a concentrated aerosol form, it
can cause ALI, which is often fatal and currently there are effective treatment modalities.
We have shown previously that THC can attenuate SEB-mediated ALI and rescue mice
from mortality.

In the current study, we investigated if the beneficial effects of THC

against SEB result from alterations in microbiota in the gut and lungs. Pyrosequencing
analysis revealed that THC caused significant and similar alterations in microbiota in the
lungs and gut of mice exposed to SEB. THC significantly increased the abundance of
beneficial bacterial species such as Ruminococcus gnavus in Firmicutes phylum but
decreased pathogenic microbiota such as Akkermansia muciniphila in Proteobacteria
phylum. Fecal microbiota transplantation (FMT) confirmed that THC-induced microbial
dysbiosis played a crucial role in THC-mediated attenuation of SEB-mediated ALI. THC
treatment also led to increase in short-chain fatty acids such as propionic acid, butyric acid
and acetic acid, of which propionic acid was found to inhibit the production of proinflammatory cytokines, while enhancing anti-inflammatory cytokines. Transcriptome
array of lung epithelial cells revealed that THC altered the expression of several genes.
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THC up-regulated several antimicrobial enzymes and peptides such as lysozyme 1 and 2,
and β-defensin 2, while downregulating β-defensin 1. Tight junction protein genes
including claudin, zonula-1(ZO-1) and occludin-1 were also up-regulated after THC
treatment. THC also caused upregulation of Mucin2 and Muc5b genes in the lung
epithelial cells from ALI mice. Together, the current study demonstrates for the first time
that THC attenuates SEB-mediated ALI by altering the microbiota in the lungs and the gut
as well as promoting anti-microbial and anti-inflammatory pathways.
3.2 Introduction
Acute lung injury (ALI) and its more severe form, the acute respiratory distress
syndrome (ARDS), are triggered by a variety of etiologic agents and SEB remain one of
them. The incidence of ALI in the Unites States is 78.9 per 100,000 persons/year and the
mortality rate is 38.5% (133). SEB is capable of inducing fatal ARDS in nonhuman
primates following airborne exposure, thereby suggesting that it can also be used as
biological warfare agent (26, 134). The ability of SEB to cause acute ARDS may be
related to the fact that it acts as a super-antigen by activating a large proportion of T cells
expressing certain V𝛽-specific T cell receptors, which leads to cytokine storm and
consequent injury to various organs, including the lungs (30).

It is difficult to treat ARDS

and thus far there are no pharmacological agents that can protect the host from SEBmediated toxicity (86, 88). Recent studies from our laboratory demonstrated that exposure
to two small doses of SEB in C3H mice can trigger acute ALI, which if left untreated, leads
to 100% mortality (96). Interestingly, we were able to show that administration of THC
prior to SEB challenge prevents such toxicity and mortality by suppressing the cytokine
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storm and enhancing immunosuppressive cytokines such as IL-10 as well as induction of
Tregs (100).
There are no effective therapeutic modalities to treat ALI. Pharmacological agents
such as corticosteroids and neuromuscular blocking agents (NMBAs) may be beneficial
for ALI patients but the mortality rate remains high (135). Δ9-Tetrahydrocannabinol (THC)
is a cannabinoid component found in marijuana (cannabis sativa L.). THC acts through
cannabinoid receptors, CB1 and CB2 that are expressed on immune cells (113). THC is
well characterized to exhibit anti-inflammatory properties. THC uses multiple pathways
to mediate immunosuppression including: 1) induction of Tregs and MDSCs (8, 114, 131),
2) apoptosis in activated T cells and dendritic cells(91, 92), 3) switch from Th1 to Th2
differentiation (136), 4) inhibition of cytokine production by upregulation of suppressor
of cytokine signaling 1 (SOCS1), a negative regulator of IFN-γ (137). We have also shown
that THC triggers epigenetic changes including alterations in the expression of miRNA
(99), and histone modifications (136). For example, in SEB-induced mouse model of ALI,
our previous studies showed that THC could modulate the expression of miR17-92 cluster
and suppress SEB-induced ALI (100).
Recent studies have shown that gut microbiome may play a critical role in disease
pathogenesis involving other organs besides the gut (138). This stems from the fact that
the gut microbiota produce short chain fatty acids (SCFA) that can travel systemically and
cause immunomodulatory changes at distant sites (139).

A recent study from our

laboratory suggested that cannabinoids can trigger dybiosis that is beneficial to the host.
For example, we found that THC and Cannabidiol can reverse the dysbiosis triggered in
the gut during an experimental Multiple Sclerosis model and that the efficacy of these
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cannabinoids to attenuate this autoimmune disease depended on their effect on microbiota
(15).
While SEB is well characterized to cause ALI through induction of inflammatory
cytokines and infiltration of mononuclear cells into the lungs, there are no studies to test if
SEB can also alter the microbiota in the lungs and the gut, and how such dysbiosis can
impact the lung inflammation and ALI. Additionally, while we have shown previously
that THC can attenuate SEB-mediated ALI, whether this results from THC-mediated
dysbiosis in the lungs, has not been previously investigated.
In this study, we comprehensively investigated the effects of THC treatment on lung
and gut microbiome, induction of anti-microbial enzymes and peptides, and nature of
immune response induced during SEB-induced ALI mice. Excitingly, our results showed
that SEB caused marked but similar alterations in microbiota found in the gut and lungs in
ALI-induced mice. Moreover, THC treatment led to reversal of such dysbiosis and
importantly Fecal Microbiota Transplantation (FMT) experiments showed that the ability
of THC to attenuate SEB-mediated ALI resulted from THC-induced alterations in the
microbiota. The current study provides evidence for the first time that the lung and gut
microbiota may play a critical role in SEB-mediated pathogenesis of ALI and thus, agents
that can reverse such dysbiosis may be helpful to treat ALI.
3.3 Materials and Methods
3.3.1 Mice:
C3H/HeJ mice were obtained from the Jackson Laboratory (Bar Harbor, Maine).
Female mice, 8–10 weeks of age, were used throughout the studies. Animals were housed
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in specific pathogen-free conditions, and all experiments were approved by Institutional
Animal Care and Use Committee.
3.3.2 Induction of ALI:
SEB was purchased from Toxin Technologies (Sarasota, FL, USA), and used in the
induction of ALI as a ‘Dual Dose’ as described previously (27). Briefly, 50 µL of SEB at
a concentration of 0.1 µg/µL (50 µg total/mouse) was intranasally administered into each
C3H/HeJ mouse with a micropipette. After 2 h, the same mouse received an intraperitoneal
injection of 100 µL of SEB at a concentration of 0.02 µg/µL ( 2 µg total/mouse)
3.3.3 Treatment of THC:
THC was dissolved in ethanol and then diluted in 1× PBS. Each mouse was treated
intraperitoneally with THC that was given at 20mg/kg, i.p immediately after first SEB
exposure. Second and third doses of THC were given i.p at 10mg/kg after 24 and 48 hours
after the first dose of THC. Control mice received the vehicle. Disease progress in mice
was assessed by the evaluation of cytokine levels in the serum, and histopathology on the
third day after SEB administration. Fecal contents were collected for 16S rRNA
pyrosequencing for microbiome metagenomics analysis and short-chain fatty acids
(SCFAs) production evaluation.
3.3.4 Collection of lung tissues:
Lung tissues were removed from mice after anesthetization. Small portions of lung
tissues were used in the isolation of bacterial DNA and histopathology, as described (101).
Lung tissues were also smashed using a Stomacher 80 Biomaster lab blender (Metrohm
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USA, Riverview, FL) in 10 mL of RPMI-1640 medium, lysed with Red Blood Lysing
Buffer (Sigma-Aldrich, St. Louis, MO) to remove red blood cells, washed with PBS,
filtered and resuspend in PBS supplemented with 5% FCS. Lung-infiltrating mononuclear
cells (MNCs) were isolated from lung cell suspensions in Ficoll-Histopaque®-1077
(Sigma-Aldrich, St Louis, MO, USA) at a 1:1 ratio under 2000rpm centrifugation for 15
min, as described (96). The lung-infiltrating mononuclear cells were stored immediately
in TRIzol reagent at -80°C freezer for RNA sequencing. Portions of lung-infiltrating
mononuclear cells were used in the measurement of proton efflux rate (PER).
3.3.5 Enzyme-linked immunosorbent assay (ELISA) of cytokines:
Serum samples were used in the measurement of cytokines including tumor necrosis
factor alpha (TNF-α), interferon gamma (IFN-γ), chemokine (C-C motif) ligand 5 (CCL5)
, monocyte chemoattractant protein-1 (MCP-1/CCL2), and transforming growth factor beta
(TGF-β), by means of ELISA according to the manufacture’s protocol. All ELISA kits of
mouse cytokines were purchased from Biolegend (San Diego, CA).
3.3.6 Histopathology of lung tissues:
Lung tissues from mice were fixed in 4% paraformaldehyde solution, dehydrated in
alcohol, and embedded in paraffin for microtome section preparation. The sections with 5
µm thick were stained with hematoxylin and eosin (H&E) and examined for inflammatory
cell infiltrates under Leica fluorescence microscope system.
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3.3.7 Immunofluorescence staining of lung tissues:
Immunofluorescence staining of lung tissues was carried out as described earlier (97).
Briefly, the sections of lung tissues were deparaffinized according to the standard protocol
and treated with the antigen-retrieval solution from Abcam (Cambridge, MA) for antigen
retrieval. The sections were washed with PBS twice, permeabilized with 0.01% Triton X100 (Sigma) for 15 min, washed three times with PBS, and then incubated overnight at 4°C
with the primary antibody from Abcam (Cambridge, MA) diluted in PBS containing 1%
FBS. Next, the sections were washed with PBS three times, incubated with anti-mouse
secondary antibody diluted in PBS with 1% FBS for 1 h at 37°C, and washed three times
with PBS. The sections were then stained with DAPI to display the nuclei in the cells,
washed three times with PBS, and finally mounted with Antifade Mounting Medium from
Vector Labs (Burlingame, CA). The sections were visualized and photographed using
Leica fluorescence microscope system. The corrected total cell fluorescence (CTCF) for
cells in the lung tissues was calculated using ImageJ software from NIH (Bethesda, MD).
MUC5AC was stained using anti-MUC5AC mouse antibody (1:200, ab3649;
Abcam,), while MUC5b was stained using anti-MUC5b mouse antibody (1:500, ab77995;
Abcam,). The Corrected Total Cell Fluorescence (CTCF) was measured using ImageJ
software. CTCF = Integrated Density – (Area of selected cell X Mean fluorescence of
background readings).
3.3.8 Flow Cytometry of immune cells:
Lung samples were collected from individual mice and treated with lysis buffer to
remove red blood cells. Single-cell suspensions were prepared and incubated with Fc block
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(anti-CD16/32) from BD Biosciences (San Jose, CA) for 15 min at 4°C to block Fc
receptors. After washing with FACS staining buffer (PBS with 1% bovine serum albumin),
single-cell suspensions were stained. To determine the phenotypical characteristics of the
infiltrating cells, mononuclear cells were stained with the fluorescent conjugated
antibodies Phycoerthyrin (PE)-conjugated anti-CD4 (clone: GK 1.5), (BV510)-conjugated
anti-Gr-1 (RB6-8c5), (Alexa floura700)-conjugated anti-CD11b (clone: M1/70), (BV421)conjugated anti-CD3 (RTK4530), (Alexa floura 647)-conjugated anti-CD8 (53-6.7),
(P/Dazzle)-conjugated anti-NK1.1(PK 136) from Biolegend (San Diego, CA, USA) For 30
min. Cells were washed two times with FACS staining buffer, re-suspended in BD
Cytofix/Cytoperm solution, and incubated for 20min. Cells were washed again two times
with BD perm/wash solution Intracellular staining of Foxp3 and were carried out using
Biolegend's Foxp3 Fix/Perm buffer set following manufacturer's instructions and using
anti- IFN-γ Alexa floura 488 (clone MF-14) , IFN-γ APC (clone XMG 1.2) from Biolegend
for 30 min at 4°C in the dark for intracellular cytokine staining. Cells were washed in FACS
staining buffer and analyzed by BD FACSCelesta flow cytometer and DIVA software.
3.3.9 Analysis of transcriptome:
Lung epithelial cells were prepared according to the procedures described by the other
investigators (140, 141). Briefly, lung samples were collected from individual mice and
injected with 1ml of dispase down trachea. Then, the trachea was tied using string, and the
lungs rinsed with cold PBS. To minimize contamination with bronchial epithelial cells,
each lung lobe was cut from the main stem bronchi. The proximal-most ¼ of each lobe
surrounding the bronchi was cut and the lobes were placed into a 50ml tube containing
dispase and rocked at room temperature for 45 mins. Cell Isolation: In a cell culture hood,
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10ml of sort buffer and 50U/ml of DNAse were added to dissociate the lung tissue. The
content was passed through 100µm, 70µm, and 40µm cell strainers over 50ml tubes. The
filtered suspension was transferred into a 15mL tube, spun for 5 min at 550g at 4°C to
pellet cells. The cells were resuspended in 10ml of sort buffer and left to recover shaking
for at least one hour at 37°C. Then to increase the lung epithelial cells enrichment and get
rid of any non-epithelial cells, CD326 antibody conjugated with PE Fluor chrome
(Biolegend – USA) was used to positively purify the cell suspension by using magnetic
microbeads (Stem Cell Technology - USA) according to manufacturer’s protocol. The
cells were kept in Qiazol (Qiagen, Valencia, CA) for 5 minutes at room temperature to
break down the cellular membrane and used in the isolation of total RNA samples
according to the manufacturer’s manual of miRNeasy Mini kit (Qiagen, Valencia, CA).
GeneChip WT plus reagent kit (Affymetrix, Santa Clara, CA) was used in the synthesis of
fragmented single-stranded cDNAs (ss-cDNAs) from the total RNA samples with primers
containing a T7 promoter sequence. The second strand cDNAs were prepared from the
first-stranded cDNAs using PCR. Next, the complimentary RNAs (cRNAs) were
synthesized and amplified using T7 RNA polymerase according to Eberwine method (104,
142), and purified by the magnetic microbeads (Affymetrix, Santa Clara, CA). The purified
cRNAs were used to synthesize the second cycle of ss-cDNAs using the 2nd-cycle primers.
Then, the second cycle of ss-cDNAs were purified by the microbeads and fragmented by
uracil-DNA glycosylase and apurinic/apyrimidinic endonuclease 1 at the unnatural dUTP
residues. The fragmented ss-cDNAs were labeled with the labeling master mix, and
hybridized in the GeneChip Hybrydization Oven 645 (Affymetrix, Santa Clara, CA) at
45˚C for 16 h with rotation at speed of 60 rpm using ClariomD chip (Affymetrix, Santa
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Clara, CA). The Hybridization chips were washed and stained at room temperature for 2 h
using GeneChip Fluidics Station 450 (Affymetrix, Santa Clara, CA). Lastly, the chips were
analyzed using GeneChip Scanner (Affymetrix, Santa Clara, CA) to profile the mouse
transcriptome arrays (MTAs). Transcriptome analysis console (TAC) was used to analyze
and interpret the MTA data for specific gene expression profiles. The dysregulation of
several specific genes was validated by real-time PCR.
3.3.10 Quantification of the genes with Real Time PCR:
To validate the genes of interest, complementary DNA (cDNA) was prepared from
isolated RNA with miScript II RT kit (Qiagen, USA), and qRT‐PCR (Bio‐Rad, USA)
was used to determine expression levels. PCR reactions were performed using miScript II
primer assay (Qiagen, USA). To quantitate gene expression, custom primers were
designed and purchased from Integrated DNA Technologies (IDT), and SSO Advanced
SYBR®Green (Bio‐Rad, USA) was used for the subsequent PCR reactions. The
sequences primers used are described in Table 1.
3.3.11 Pyrosequencing of microbiome:
Lung tissues and colon samples were used in pyrosequencing for microbiome analysis,
as described previously (143). Briefly, the extraction of genomic DNA from lung tissues
and colon samples was carried out using the QIAamp DNA Stool Mini Kit (Qiagen,
Valencia, CA) according to the manufacture's instruction. The DNA concentrations were
determined using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific,
Waltham, MA) and stored at −20°C for further analysis. The 16S rRNA V3-V4
hypervariable regions of bacterial DNA were amplified by PCR using the 16S V3-314F
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forward

primer

(5′-

TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG3′)

and

reverse

V4-805R

primer

(5′-

GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAA
TCC-3′) at 95°C for 3 min and 25 cycles of 95°C 30 s, 55°C 30 s and 72°C 30 s, and a final
extension at 72°C for 5 min (144). Illumina (San Diego, CA) adapter overhang nucleotide
sequences were added, and the reactions were cleaned up with AgencourtAMPure XP
beads. Then, both dual indices and Illumina sequencing adapters were attached by PCR
using the reaction mixture of 5 µL of amplicon PCR product DNA, 5 µL of Illumina
Nextera XT Index Primer 1 (N7xx), 5 µL of Nextera XT Index Primer 2 (S5xx), 25 µL of
2× KAPA HiFi Hot Start Ready Mix and 10 µL of PCR-grade water at 95 °C for 3 min and
8 cycles of 95°C 30 s, 55°C 30 s and 72°C 30 s, and a final extension at 72°C for 5 min.
Next, the constructed 16S metagenomic libraries were purified with AgencourtAM Pure
XP beads and quantified with Quant- iTPicoGreen. Library quality and average size
distribution were determined with the Agilent Technologies 2100 Bioanalyzer. Amplicons
in the libraries were subject to pyrosequencing using the MiSeq Reagent Kit V3 in the
Illumina MiSeq System. Sequenced data collected from the Illumina Miseq system were
analyzed by means of the online 16S analysis software from NIH, known as Nephele
(https://nephele.niaid.nih.gov/) to determine microbial compositions.
3.3.12 Fecal microbiota transplant (FMT):
Colonic materials were collected from 8 donor mice in each group and used in fecal
microbiota transplant, as described (15). Recipient mice were extensively treated with
different antibiotics (i.e. ABX cocktail) for 4 weeks in drinking water to ensure the
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complete depletion of endogenous microbiome as described previously (145, 146). The
ABX cocktail was composed of 250 mg/ml bacitracin, 170 µg/ml gentamycin, 125 µg/ml
ciprofloxacin, 100 µg/ml neomycin, 100 µg/ml metronidazole, 100 µg/ml ceftazidime, 100
U/ml penicillin, 50 µg/ml streptomycin and 50 µg/ml vancomycin.

This cocktail was

replaced with freshly prepared cocktail every 5 days during the antibiotic treatment period.
The complete depletion of endogenous microbiome in the gut of recipient mice was
confirmed by PCR validation and bacteriological culture. Fecal pellets were collected
aseptically under anaerobic conditions by enriching the chamber environment with special
gas mixture (Praxair, Columbia, SC) from all recipient mice three days before the end of
antibiotics treatment for the confirmation of complete depletion of endogenous
microbiome in the gut. Recipient mice received oral administration of normalized amount
of fecal materials in PBS from each group of mice twice using tuberculin syringes in the
anaerobic chamber to protect collected gut anaerobic bacteria from free oxygen during
fecal microbiota transplant. Immediately after FMT, the recipient mice received the first
intranasal administration of SEB. After 24 h, the recipient mice received the second
intraperitoneal injection of SEB, as described above. Disease progress in mice was
assessed by the evaluation of mouse survival for 30 days. On the third day after SEB
administration, 5 mice form each group were sacrificed for the preparation of lunginfiltrating mononuclear cells for flow cytometry analysis, and for the collection of caecum
contents for 16S rRNA pyrosequencing analysis.
3.3.13 Identification and quantification of colon SCFAs:
Colon samples were suspended and homogenized in water. After centrifugation for
10 min at 12,000 rpm, the supernatant was collected and acidified by HCl. 4-methylvaleric
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acid as internal standard was added into the supernatant at a final concentration of 258 µM.
SCFAs were identified and quantified by HP 5890 gas chromatograph configured with
flame‐ionization detectors (147) (99). Data were collected using the Varian MS
Workstation (version 6.9.2.) software. The linear regression equation was used to calculate
the concentration of different SCFAs in colon samples.
3.3.14 Effect of SCFAs on T cell functions:
T cells were isolated from splenocytes by PE Selection Kit from STEMCELL
Technologies (Cambridge, MA) according to the protocol from the company. The isolated
T cells were cultured at 37 °C in 5% CO2 in the media supplemented with 10% fetal bovine
serum in the presence of 1 mM propionic acid (MilliporeSigma, St. Louis, MO) after
stimulation with 1 µg/ml of SEB. After culture for 3 days, the T cells were collected for
proton efflux rate, and culture supernatants were tested for cytokine quantification by
ELISA.
3.3.15 Measurement of proton PER:
Lung-infiltrating mononuclear cells or purified T cells (2×105 ) were seeded in each
well in XFp cell culture plate (Agilent, Santa Clara, CA) pre-coated with CellTak
(Corninng, Corninng, NY) to adhere seeded cells onto the bottom of wells during analysis.
Glycolysis Rate Assay kit (Agilent) was used for the measurement of PER in the purified
T cells according to manufacturer’s protocol. Briefly, Seahorse XF Base Medium without
phenol red was enriched with 2mM glutamine, 10mM pyruvate and 5mM HEPES, and then
the PH were adjusted at ~7.4. Injections cartridge (Agilent) was used to deliver different
assay chemicals while performing GRA to achieve final concentrations of 5µM of
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Rotenone/Antimycin (Rot/AA) and 500 mM 2-DG in each well. About every 3 minutes,
the Seahorse XFp system measured the concentrations of oxygen and changes in PH values
in the wells and converted them as oxygen consumption rate (OCR) and extra cellular
acidification rate (ECAR), respectively. Lastly, Desktop Report Generator software
(Agilent) was used to interpret the acquired data and calculate PER in the purified T cells.
3.3.16 Statistical Analysis:
All in vitro studies were carried out in triplicate. All in vivo studies were performed
with at least 10 mice in each group, as determined by the power analysis. GraphPad Prism
8.0 software was used in the statistical analysis. Student's t-test was used to compare two
groups, whereas multiple comparisons were made using one-way ANOVA, followed by
post hoc analysis using Tukey's method. For least discriminative analysis (LDA)
calculation, Galaxy online software (huttenhower.sph.harvard.edu/galaxy) was used to run
LEfSe and create LDA and cladogram plots based on Alpha value for the factorial
Kruskal-Wallis test among classes, Alpha value for the pairwise Wilcoxon test between
subclasses and Threshold on the logarithmic LDA score for discriminative features ≥2
unless stated differently. A p-value of <0.05 was considered statistically significant.
3.4 Results
3.4.1 Role of THC in the inhibition of ALI:
Our previous study demonstrated that treatment of mice with THC prior to SEB
exposure, attenuates lung injury through miRNA 17-92 cluster in ALI mouse model (100).
Because SEB is a superantigen that triggers acute inflammation, in the current study, we
tested if treatment with THC after SEB sensitization would attenuate lung inflammation.
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Histopathological analysis demonstrated that THC could attenuate acute lung injury,
reduce congestion and minimize fibrin in mice with ALI which was accompanied by a
decrease in the infiltration of the immune cells in the lung tissues when compared to vehicle
controls (Fig. 3.1A). THC also significantly decreased the serum levels of proinflammatory cytokines including TNF-α, IFN-γ, CCL5 and MCP-1, but increased the
serum levels of anti-inflammatory cytokines such as TGF-β in ALI mice when compared
to vehicle control group (Fig. 3.1B). THC significantly decreased the number of
mononuclear cells isolated from the lungs from ALI mice (Fig. 3.1C). THC also
significantly decreased the numbers of T cells, CD4+ T cells and CD8+ T cells in the lungs
from ALI mice (Fig 3.1D). In addition, THC significantly decreased the proton efflux rate
(PER) in the mononuclear cells isolated from the lungs from ALI mice, suggesting that
THC may suppress glycolysis in cell metabolism (Fig. 3.1E). These data together
demonstrated that THC attenuates SEB-mediated inflammation in the lungs.
3.4.2 Effects of THC on the regulation of microbial dysbiosis in ALI:
We were interested in the understanding of functions of THC in the regulation of
microbial dysbiosis in ALI.

Our pyrosequencing analysis demonstrated that THC

dramatically altered microbiota in the lung tissues as shown in both the PCoA beta diversity
plot (revealing the clustering patterns) and cladogram (displaying potential microbial
biomarkers) from linear discriminant analysis effect size (LEfSe) analysis (Fig. 3.2A).
THC also considerably changed microbiota in the colon (Fig. 2B). The microbial specieslevel analysis in the lungs revealed that THC significantly increased the species of
Ruminococcus gnavus, but significantly decreased the species of Bacteriodies acidifaciens
and Akkermansia muciniphila in the lungs from ALI mice (Fig. 3.2C). Similarly, THC
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significantly increased the species of Ruminococcus gnavus, but significantly decreased
the species of Akkermansia muciniphila in the colon from ALI mice (Fig. 3.2D). In
addition, our analysis also showed that THC drastically changed microbiota in the blood
from ALI mice (Fig. 3.6A). Similar to the lungs and colon, THC increased the species of
Ruminococcus gnavus, but decreased the species of Akkermansia muciniphila in the blood
from ALI mice (Figs. 3.6B – 3.7). The results demonstrated that THC could significantly
increase the species of Ruminococcus gnavus, but significantly decrease the species of
Akkermansia muciniphila systemically following SEB exposure. Ruminococcus gnavus
could be considered as beneficial bacteria because it modulates mucin in the mucus which
is a protective layer in many lining tissues in the body (34). Thus, we examined mucin
expression in the lung by immunofluorescence staining. We found that THC significantly
inhibited the expression of mucin MUC5ac (Fig. 3.2E), but significantly increased the
expression mucin MUC5b (Fig. 3.2F). It has been reported that MUC5ac is associated
with inflammation and airway obstruction (35), whereas MUC5b plays a role in
mucociliary clearance, controlling infections in the airways and maintaining immune
homeostasis in mouse lungs (36). Additionally, THC significantly inhibited Evans blue
extravasation in the lungs and FITC-dextran levels in the serum thereby suggesting that
THC was blocking the vascular leak induced by SEB (Fig. 3.2G). Similarly, THC
significantly inhibited the concentrations of lipopolysaccharides in the BALF and serum
of SEB exposed mice (Fig. 3.2H).
3.4.3 Effect of THC in the regulation of gene expression in lung epithelial cells:
Because lung epithelial cells play a crucial role in barrier integrity and many other
functions, we next examined the expression of genes in these cells from ALI mice after
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THC treatment. To that end, we performed transcriptome array analysis using total RNAs
isolated from the lung epithelial cells. Data obtained from the transcriptome array analysis
showed altered expression of a large number of genes in the epithelial cells after THC
treatment (Fig. 3.3). Specifically, the volcano plot analysis demonstrated dysregulation of
1553 genes in the epithelial cells from ALI mice after THC treatment (Fig. 3.3A). The 29
most significantly dysregulated genes induced by THC were shown in the Heat map (Fig.
3.3B). Among 29 dysregulated genes, several genes were particularly related to
antimicrobial enzymes, antimicrobial peptides, tight junction proteins and mucins (Fig.
3.2B). The up-regulation of antimicrobial enzyme genes [including lysozyme 1 ((LYZ1)
and LYZ2] and antimicrobial peptide gene, beta-defensin 2 (defb2), and the
downregulation of antimicrobial peptide gene beta-defensin 1 (defb1) were validated by
real-time PCR (Fig 3.3C). Tight junction protein genes including claudin, zonula-1(ZO-1)
and occludin-1 were up-regulated after THC treatment (Fig 3.3D). Mucin2 and Muc5b
genes were also up-regulated significantly in the lung epithelial cells from ALI mice after
THC treatment (Fig 3.3E). It has been reported that the epithelial tissue secretes different
antimicrobial peptides to fight against different microorganisms (34). These results
suggested that THC may regulate the pathogenic microbiota promoted by SEB through
induction of antimicrobial peptides.
3.4.4 Effects of fecal microbiota transplantation on SEB-mediated ALI:
FMT has been shown to replenish bacterial balance (144). Thus, FMT was used to test
the role of THC-induced microbial dysbiosis in the attenuation of ALI. To that end, colonic
material was obtained from different treatment groups including vehicle controls, THC,
SEB+Vehicle, and SEB+THC-treated group and transplanted into recipient mice that had
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been treated with antibiotics for 4 weeks and then exposed to SEB. Survival data showed
that all SEB-challenged mice that received FMT from SEB+vehicle or vehicle alone group,
died within 10 days, whereas recipient mice that received FMT from SEB+THC group
showed 80% survival for more than 30 days (Fig. 4A). Also, 60% of recipient mice that
received FMT from THC alone treated group survived SEB challenge. These data
suggested that the microbiota from SEB+THC group had protective effect on SEBmediated pathogenesis. After FMT, colonic material was further examined for microbiota
and we found that different treatment groups showed distinct clusters and composites of
microbiota as shown in both the PCoA beta diversity plot and cladogram from LEfSe
analysis (Fig. 3.4B and Fig. 3.4C). Linear discriminant analysis showed that Proteobacteria
phylum significantly decreased in mice that received FMT from SEB+THC group when
compared to mice that received FMT from SEB+Vehicle group. Additionally, Firmicutes
phylum was significantly increased in mice that received FMT from SEB+THC group
when compared to SEB+Vehicle group (Fig. 3.4D and Fig. 3.4E). Next, we tested if FMT
could also induce alterations in immune cells in the lungs of recipient mice. After the FMT
of colonic materials from SEB+THC-treated mice, the percentages of both CD4+ and
CD8+ T cells significantly decreased in the lungs of recipient mice when compared
recipient mice that received FMT from SEB+vehicle treated group (Fig. 3.4F and Fig.
3.4G). In contrast, in the mice that received FMT from SEB+THC-treated group, the
percentages of immunosuppressive cells such as regulatory T cells (Tregs) and myeloid
derived suppresser cells (MDSCs) significantly increased in the lungs when compared to
controls (Fig. 3.4H and Fig. 3.4I). These data together suggested that THC-induced
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microbial dysbiosis was playing a beneficial role in suppressing SEB-induced ALI
pathogenesis.
3.4.5 Effects of THC on short-chain fatty acids in ALI:
Because of the positive role played by THC-mediated microbial dysbiosis, we next
measured short chain fatty acids (SCFAs) know to play anti-inflammatory role. Thus, we
quantified the concentrations of SCFSs in the caecum flush from SEB+THC treated mice
and our data showed that the concentrations of propionic acid, butyric acid and acetic acid
significantly increased in these mice when compared to the controls (Fig. 3.5A). To further
elucidate the role of SCFAs in inflammation, we used in vitro cultures of T cells activated
with SEB in the presence of propionic acid (PA). We found that in such cultures, addition
of PA significantly inhibited the production of pro-inflammatory cytokines including IFNγ, IL-17 and IL-1β, but significantly increased the production of anti-inflammatory
cytokines such as IL-10 (Fig. 3.5B). PA also significantly inhibited the proton efflux rate
in T cells after SEB activation (Fig. 3.5C). These data suggested that short-chain fatty acids
such as PA suppressed the pro-inflammatory responses and thus may play a role in the
control of ALI pathogenesis.
3.5 Discussion
ALI is a life-threatening complication that can result following Staphylococcus aureus
infection. The enterotoxin produced by these bacteria, SEB, acts as a superantigen thereby
activating a large proportion of T cells expressing certain Vβ specificities leading to
cytokine storm and severe lung injury. Previous studies have shown that pro-inflammatory
cytokines such as IL-1β, IL-6, IL-8 and TNF-α and inflammatory mononuclear cells are
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significantly increased in both ALI patients and mice exposed to SEB (35, 148, 149). The
current therapeutic approaches are inadequate because of which this devastating illness
leads to high mortality rates, to the tune of 30–40% (133). While microbiota found in the
gut has been known to play a critical role in regulating inflammation, the role of resident
microbiota during ALI induced by SEB has not been investigated previously. In the current
study we make several important observations: 1) THC when administered after SEB
exposure, can attenuate SEB-mediated ALI. 2) Exposure to SEB induces dysbiosis in the
lungs and gut 3) THC triggers similar dysbiosis in the lungs and gut and THC-mediated
attenuation of ALI depends on alterations in the microbiota 4) FMT studies demonstrate
that THC-mediated alterations in the lung microbiota may play a beneficial role in
attenuating ALI.
Studies from our laboratory and elsewhere have shown that THC acts as a potent antiinflammatory agent (113). For instance, THC could significantly decrease the levels of
pro-inflammatory cytokines such as IFN-γ and TNF-α, but increase anti-inflammatory
cytokines such as IL-10 and TGF-β (150, 151). Furthermore, THC has been shown to
decrease Th1 cells while promoting Tregs and MDSCs (113, 114, 152). These studies are
consistent with

our current findings THC significantly inhibited infiltration of

mononuclear cells in the lung, decreased serum levels of pro-inflammatory cytokines
including TNF-α, IFN-γ, CCL5 and MCP-1, while increasing anti-inflammatory cytokines
TGF-β, decreased the number of CD3, CD4+ and CD8+ T cells, and suppressed the proton
efflux rate in the lung-infiltrating mononuclear cells (Fig. 3.1). Inflammation in the lung
also triggers structural remodeling of the airway involving epithelial cells, including
increased extracellular deposition, and expansion of pro-fibrotic myofibroblast populations
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A few recent studies revealed that THC could alter gut microbiota in diet-induced
obesity and experimental autoimmune encephalomyelitis (EAE)-induced mice (15, 153,
154). Thus far, there are no studies delineating the effect of SEB or THC on lung
microbiota. Thus, it was interesting to note that THC treatment in SEB-challenged mice
led to similar changes in microbiota in both the gut and lungs inasmuch as we noted that
THC significantly increased the abundance of bacterial species Ruminococcus gnavus in
Firmicutes phylum but decreased that of Akkermansia muciniphila (Figs. 2 and S1).
Ruminococcus gnavus is a human gut symbiont, and is known to play an important role in
the regulation of mucin expression and glycosylation (155). Specifically, Ruminococcus
gnavus increased the expression of glycoproteins and Muc2 in goblet cells in the colonic
mucosa from mice (155). Mucin is one of the most important components of mucus and
plays a crucial role in the defense against bacterial pneumonia, maintenance of the integrity
of lung tissue and prevention of vascular leak (156, 157). Besides, Ruminococcus gnavus
produced peptides such as ruminococcin A (RumA) and RumC, have high activity against
pathogenic clostridia and exhibit other antimicrobial activities (158, 159). In contrast,
Akkermansia muciniphila is widely present in the intestines of humans and animals, and
known to induce IgG1 antibodies and antigen-specific T cell responses, and thus enhancing
immune responses (160). Indeed, it has been reported that Akkermansia muciniphila
increased the expression of pro-inflammatory cytokines such as IFN-γ, IP-10, TNF-α, IL6, IL-12 and IL-17 in the colon and colonic tissues from mice (161). In addition,
Akkermansia muciniphila has a specialized ability in mucin degradation and excessive
mucin degradation may induce inflammation (161, 162). These results suggested that THC
could modulate microbial dysbiosis in the lung, particularly increase the abundance of

56

Ruminococcus gnavus, but decrease that of Akkermansia muciniphila, which were
responsible for the induction of mucin expression, inhibition of the pro-inflammatory
responses and suppression of pathogenic bacteria, leading to the attenuation of ALI (40).
Because the epithelial cells play several important functions such as barrier
protection, fluid balance, mucus and surfactant production, and repair following injury, in
the current study, we investigated the effect of SEB and treatment with THC, on gene
expression in lung epithelial cells. Our analysis showed that THC caused altered expression
of over 1553 genes in the lung epithelial cells from ALI mice, and particularly several
dysregulated genes were related to antimicrobial enzymes, antimicrobial peptides, tight
junction proteins and mucins (Fig. 3.3A and 3.3B). Further study revealed that THC upregulated the gene expression of mucins such as Mucin2 and Muc5b (Fig. 3.3E) and tight
junction proteins such as claudin, ZO-1 and occludin-1 in the lung epithelial cells from
ALI mice (Fig. 3.3D). Mucins are highly glycosylated proteins, which are the major
components of the mucous on the surface of respiratory and digestive tracts and protect
epithelial cells from infection, dehydration, and physical or chemical injury (41, 42). THC
treatment increased the production of tight junction proteins indicating its role in protecting
cell integrity (43, 44). Therefore, THC may increase the gene expression of mucins and
tight junction proteins, and thus have protective effect during SEB-mediated ALI. Most
interestingly, our study discovered that THC up-regulated gene expression involving
antimicrobial enzymes such as LYZ1 and LYZ2, and antimicrobial peptide gene defb2, but
down-regulated gene expression of other antimicrobial peptides such as defb1, in the lung
epithelial cells from ALI mice (Fig. 3.3). It has been reported that the host-derived
antimicrobial enzymes such as lysozyme in the mucus protect from harmful bacteria (45).
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There are other reports which have shown that lung injury is associated with alterations in
β-defensin. For example, elevated β-defensin-1 protein was seen in chronic obstructive
pulmonary disease (COPD) and severe asthma (46, 47). Additionally, β-defensin-2 has
been shown to play both an anti-inflammatory and anti-microbial role. Overexpression of
β-defensin-2 was shown to protect against P. aeruginosa and cecal ligation and double
puncture-induced lung injury (48). Thus, the ability of SEB to induce β-defensin-2 and
decrease β-defensin-1 correlates with the ALI pathogenesis and in this context, it is
interesting to note that THC reversed these effects.
While we did see significant dysbiosis following THC treatment, it was not clear if
this played any role in the attenuation of SEB-mediated ALI. To that end, we pursued
FMT studies which conclusively demonstrated that THC-mediated alterations in
microbiota play a crucial role in the attenuation of SEB-meditated ALI. The most exciting
finding was that antibiotic treated mice that received FMT from SEB+Vehicle group, all
died within 8 days of SEB challenge while those that received FMT from SEB+THC group,
80% survived beyond 30 days, thereby demonstrating that THC-mediated dysbiosis was
playing a crucial role in attenuating SEB-induced ALI. The fact that FMT from THC alone
treated mice also provided 60% protection against SEB also supported the above findings.
Thus, it is likely that THC-mediated increase in the abundance of beneficial bacteria such
as Ruminococcus spp. in Firmicutes phylum, and decrease in pathogenic bacteria in
Proteobacteria phylum, may help in attenuating ALI.
Recent studies have shown that SCFAs including acetate, propionate and butyrate are
main bacterial metabolites and play critical roles in human health and diseases (163, 164).
Because THC could induce microbial dysbiosis in ALI mice (Figs. 3.2 and 3.4), it was
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expected that THC also affected the production of SCFAs. Our analysis showed that THC
significantly increased the levels of propionic acid, butyric acid and acetic acid in the colon
flash from ALI mice (Fig. 5). Furthermore, propionic acid significantly inhibited the
production of pro-inflammatory cytokines but significantly increased the production of
anti-inflammatory cytokines (Figs. 3.5). It has been reported that SCFAs could activate Gcoupled-receptors, suppress histone deacetylases, affect energy metabolism, and thus
regulate inflammatory responses (165). Specifically, SCFAs could inhibit the production
of pro-inflammatory cytokines, and suppress proliferation, activation and migration of
immune cells (164). Investigations also discovered that Ruminococcus gnavus produced
propionate and propanol as the end products of metabolism (153). These results suggested
that THC may increase the abundance of bacterial species such as Ruminococcus gnavus
in Firmicutes phylum, promote the production of short-chain fatty acids such as propionic
acid, and thus suppress the pro-inflammatory responses, resulting in the attenuation of
acute lung injury. Thus, the FMT may have worked to attenuate ALI because of the
induction of SCFA. In summary, the current study demonstrates that THC triggers
dysbiosis in the lungs and gut and such dysbiosis promotes SCFA, antimicrobial peptides
and enzymes, and mucin to help prevent pathogenic bacteria from mediating injury as well
as promote an anti-inflammatory environment in the lungs thereby protecting the mice
from SEB-mediated ALI.
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Figure 3.1: Effect of THC on lung inflammation in SEB induced ALI. C3H mice were
injected with SEB followed by THC or vehicle as described in Methods. Representative
images of histopathological H&E staining sections of excised lung tissues were shown (A).
Enzyme-linked immunosorbent assay (ELISA) was used in the measurement of serum
cytokines and chemokines (B). The change in total number of mononuclear cells isolated
from the lungs was shown (C). Flow cytometry was used in the analysis of changes of
CD3+, CD3CD4+ and CD3CD8+ T cells in the lung-infiltrating mononuclear cells from
ALI mice after THC treatment (D). The inhibitory effect of THC on the proton efflux rate
(PER) on PE-selected CD3+ cells (E). Vertical bars represent data expressed as
Mean±SEM with five mice in each group. * p<0.05, ** p<0.01, *** p<0.001, and ****
p<0.0001.
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Figure 3.2: Effects of THC on the abundance of microbiota in the lung and colon from ALI
mice. Lung and colon content samples were collected from different treatment groups
described in Figure 1 and microbial communities’ compositions were determined by 16S
rRNA sequencing and analyzed by using QIIME through Nephele platform. The effects of
THC on microbiota compositions in the lung tissues were shown in the PCoA beta diversity
plot (revealing the clustering patterns) on the left and cladogram (displaying potential
microbial biomarkers) from linear discriminant analysis effect size (LEfSe) analysis on the
right (A). Similarly, the effect of THC on microbiota compositions in the colon was
displayed in the PCoA beta diversity plot on the left and cladogram from LEfSe analysis
on the right (B). The effects of THC on the abundances of bacterial species including
Ruminococcus gnavus, Bacteroides acidifaciens and Akkermansia muciniphila in the lung
were depicted (C). The effects of THC on the abundances of bacterial species including
Ruminococcus gnavus and Akkermansia muciniphila in the colon were depicted (D). The
effect of THC on the expression of MUC5ac in the lung tissues was determined by
immunofluorescence staining and exhibited (E). The effects of THC on the expression of
MUC5b in the lung tissues was determined by immunofluorescence staining and presented
(F). The effect of THC on lung vascular permeability was determined by the measurement
of concentrations of Evans blue in the lung tissues, and FITC-dextran in the serum (G).
The effects of THC on the concentrations of lipopolysaccharide (LPS) in the BALF and
serum were shown (H). Data were presented as Mean±SEM of multiple experiments from
five mice in each group. * p<0.05, and ** p<0.01.
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Figure 3.3: Effect of THC on the transcriptional profiles of gene expression in the
pulmonary epithelial cells from SEB-induced ALI. Lung epithelial cells were isolated from
mice which were challenged with SEB followed by THC or Vehicle as described in Fig 1
legend. The differences of gene expression between THC-treated group and vehicle
control group were shown in the scatter plot (A). The expression differences of selected
genes between THC-treated group and vehicle control group were presented in the heat
map (B). Quantitative validations of the differential expressions of genes has been
presented, including lysozyme1, lysozyme2, beta-defensin1 and beta-defensin2 (C);
claudin, ZO-1 and occluding-1 (D); mucin2 and MUC5b (E). Data were presented as
Mean±SEM of multiple experiments from five mice in each group. * p<0.05, and **
p<0.01.
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Figure 3.4: Effects of FMT on microbiota reconstitution and ALI pathogenesis. Colonic
material from various groups described in Figure 1were transferred into antibioticmicrobiome-depleted recipient mice that were challenged with SEB. The survival of such
recipient mice was studied (A). The effects of FMT of colonic materials from mice of
different treatment groups on the microbiota reconstitution in the colon of ALI recipient
mice was displayed in the PCoA beta diversity plot (B) and cladogram from LEfSe analysis
(C). Linear discriminant analysis (LDA) scores were calculated for comparing differential
abundance of microbiota in the caecum from recipient mice after FMT of colonic materials
from various groups and shown in the histogram plot (D). The effects of FMT of colonic
materials from SEB+Veh and SEB+THC groups on the bacterial abundances of Firmicutes
and Proteobacteria phylum in the colon from ALI recipient mice (E). The effects of FMT
of colonic materials from SEB+Veh and SEB+THC groups on the percentages of CD4+ T
cells in the lungs (F), CD8+ T cells (G), CD4+Foxp3+ Treg cells (H), CD11b+Gr-1+
MDSCs (I). Vertical bars represent data expressed as Mean±SEM from groups of 5 mice.
** p<0.01, and ***p<0.001.
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Figure 3.5: Effects of THC on the production of SCFAs and roles of propionic acid in T
cells. Mice were treated with SEB followed by Vehicle (SEB+Veh) or THC (SEB+THC)
as described in Fig 1. Colon flush was collected, and short chain fatty acids quantified by
HP 5890 gas chromatograph configured with flame‐ionization detectors. The effects of
THC on the concentrations of propionic acid, butyric acid and acetic acid in the colon flush
mice injected with SEB (A). Splenocytes harvested from naïve C3H/HeJ mice were
cultured and activated with SEB along with Propionic acid (PA). The effects of propionic
acid on the production of IFN-γ, IL-17, IL-1β and IL-10 from in vitro cultured T cells after
SEB activation was determined by ELISA (B). The effects of propionic acid on the proton
efflux rate in cultured T cells after SEB activation was determined by a Seahorse XF24
analyzer (C). Data were presented as Mean±SEM from five mice or five replicates in each
group. * p<0.05, ** p<0.01, and *** represented p<0.001.
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Figure 3.6: Effects of THC on the abundance of microbiota in the blood from ALI mice.
The blood samples were collected from different treatment groups of mice and microbial
compositions were determined by 16S rRNA sequencing. The effect of THC on microbiota
compositions in the blood was shown in the PCoA beta diversity plot on the left and
cladogram from LEfSe analysis on the right (A). The effects of THC on the abundances of
bacterial species including Ruminococcus gnavus, Akkermansia muciniphila and
Lactobacillus iners in the blood was depicted (B). Data were presented as Mean±SEM
(error bars) of multiple experiments from five mice each group. * p<0.05, and ** p<0.01.
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Figure 3.7: Comparison of THC-induced microbial dysbiosis in the lung, colon, and blood
from ALI mice. Venn diagram was used in the display of common microbiota found in the
lung, colon and blood from naïve or SEB-induced ALI mice following treatment with THC
or vehicle.
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CHAPTER IV
USE OF SINGLE CELL RNA SEQUENCING LEADS TO
IDENTIFICATION OF APOPTOTIC PATHWAYS IN IMMUNE CELL
SUBSETS IN MICE EXPOSED TO STAPHYLOCOCCAL
ENTEROTOXIN B FOLLOWING TREATMENT WITH Δ9TETRAHYDROCANNABINOL
4.1 Abstract
Inhalation of the bacterial superantigen, staphylococcal enterotoxin B (SEB) induces
acute lung injury (ALI), which is characterized by overwhelming inflammation and loss of
respiratory function. Studies from our laboratory have shown that Δ9-tetrahydrocannabinol
(THC), a psychoactive ingredient found in Cannabis sativa, has immunosuppressive
properties. In this study, we investigated the anti-inflammatory effects of THC on ALI
induced by exposure to SEB. We found that treatment of mice with THC after SEB
administration led to attenuation of SEB-induced lung inflammation via induction of
immune cell apoptosis, suppression of T cell proliferation, and reduction of
proinflammatory cytokines and chemokines such as IL-1β, IL-2, CCL2 and CCL5.
Furthermore, THC-induced apoptosis was due to loss in mitochondrial membrane
potential. Transcriptomic analysis of lung-infiltrating mononuclear cells revealed increase
in mitochondrial respiratory chain enzymes such as cytochrome c oxidases genes following
THC treatment which may be involved in cytochrome C release during apoptosis.
Interestingly, single cell RNA sequencing of lungs showed that THC treatment induced
mitochondrial pathway associated pro-apoptotic genes, Bad, Apopt1, and Casp3 in CD4+
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and CD8+ T cells. In addition, metabolomic analysis revealed elevated serum
concentrations of the amino acids, lysine, n-acetyl methionine, carnitine and propionyl Lcarnitine in THC-treated mice which are involved in fatty acid transport across
mitochondrial membranes. Moreover, metabolic assays in SEB-activated T cells
demonstrated that THC promoted a shift from dependency on glucose oxidation to fatty
acid oxidation. To determine potential miRNA involved in THC-mediated induction of
apoptosis, we performed pathway analysis and expression validation of candidate
microRNA (miR) in lung mononuclear cells (MNC). Specifically, THC treatment led to
downregulation of miR-185 and a correlative increase in pro-apoptotic gene targets such
as Bad, Bax and Hrk. Collectively, this study demonstrates that THC treatment alleviates
SEB-induced ALI through regulation of miRs that promote the mitochondrial pathway of
apoptosis in SEB-activated T cells.
4.2 Introduction
Staphylococcal enterotoxin B (SEB) is a superantigen that promotes acute
inflammation due to triggering polyclonal expansion of T cells (166). Depending on the
route of exposure, SEB can promote toxic responses leading to food poisoning, toxic shock
syndrome, or acute lung injury (ALI). Inhalation of SEB promotes ALI, a life-threatening
condition that is characterized by leukocyte infiltration, pro-inflammatory cytokine
production, and breakdown of the lung barrier. Previous reports from our laboratory have
shown beneficial effects of anti-inflammatory plant products in the prevention of SEBinduced ALI (96, 100, 101) .
Interestingly, Δ9-tetrahydrocannabinol (THC) is a psychoactive cannabinoid derived
from Cannabis sativa that has potential therapeutic value for pain relief, control of nausea
70

and vomiting, appetite stimulation, and anti-inflammatory properties (167). Indeed, a
previous report from our laboratory showed that exposure to THC prior to the
administration of SEB can prevent SEB-induced ALI and associated mortality through
miRNA (miR) regulation of regulatory T cells (100) . Consequently, this study was aimed
at identifying the mechanisms underlying the ameliorative effects of THC on ALI induced
following exposure to SEB.
Apoptosis is a form of highly-regulated programmed cell death that can be triggered
through intrinsic (mitochondrial) or extrinsic (death receptor-mediated) signaling pathways
(168). Here, we attempted to clarify the role of THC in inducing apoptosis in immune cells
as a mechanism of immunosuppression. Activation of the intrinsic pathway is mediated
by the B-cell lymphoma 2 (Bcl-2) family of proteins that are associated with the
mitochondria and mechanistically detailed elsewhere (169).Of note, pro-apoptotic proteins
include BH3 interacting domain death agonist (Bid), Bcl2-associated agonist of cell death
(Bad), Bcl-2-like protein 11 (Bim), Bcl-2-modifying factor (Bmf), inducer of apoptosis
harakiri (Hrk), p53 upregulated modulator of apoptosis (Puma), Phorbol-12-myristate-13acetate-induced protein 1 ( PMAIP1) also known as (Noxa), Bcl-2 associated X protein
(Bax), Bcl-2 homologous antagonist/killer (Bak) and Bcl-2 family apoptosis regulator
(Bok) (170). Our laboratory and others have indicated THC can induce apoptosis in
different cell types (91, 92, 171). In T cell leukemia (Jurkat cell line) cells, for instance, a
study from our lab had shown that THC can induce apoptosis via cross talk between
intrinsic and extrinsic pathways (172). Thus, in the current study we determined whether
THC induces apoptosis in activated immune cells in the lungs following SEB-induced ALI,
and if so, whether it was through the death receptor or mitochondrial pathway.
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Single-cell RNA Sequencing (scRNASeq) is a relatively novel and powerful
technique for quantitating the transcriptome of various cell types in tissues based on
molecular characteristics rather than on morphology or proteins in cells (173).

In the

current study, we have used this technology to unveil the precise cells and molecular
signatures that may be involved in THC-mediated induction of apoptosis. Furthermore,
the data have been integrated with our findings from metabolomic analysis of serum
metabolites as well as cellular respiration, mitochondrial function and metabolism. In
recent years, miRNAs (miRs) have been identified to suppress multiple genes, and thus
regulate biological processes (174). Studies from our lab had shown the ability of THC to
suppress neuroinflammation by downregulation of

miR-21 which upregulates

Bcl2L11(99). Furthermore, we demonstrated that miR-690 targeted C/EBPα gene after
THC treatment which caused elevation of anti-inflammatory myeloid-derived suppressor
cells (MDSCs) (175) . In the current study, we investigated the mechanisms by which THC
could induce apoptosis in immune cells to attenuate ALI induced by SEB. Our data
demonstrated that THC decreased the expression of miR-185-3p in SEB-activated immune
cells thereby promoting the induction of a number of genes related to the mitochondrial
pathway of apoptosis, causing alteration in metabolism of immune cells, leading to
attenuation of inflammation and ALI.
4.3 Materials and Methods
4.3.1 Exposure of mice with SEB and THC:
Adult female C3H/HeJ mice were purchased from The Jackson laboratory (JAX Stock
# 000659). Mice were housed in an AAALAC-accredited, specific pathogen free animal
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facility at the University of South Carolina School of Medicine. All mouse experiments
were performed under protocols approved by the Institutional Animal Care and Use
Committee. To induce ALI, SEB was delivered according to the “dual dose” model
described previously (27) . This approach causes 100% mortality with the low
concentration of SEB, and triggers ALI in C3H/HeJ mice. In brief, SEB dissolved in sterile
PBS, was administered first by intranasal (i.n.) route at a concentration of 5 μg per mouse
in 25 μl volume. Two hours later, a second dose of SEB was delivered (i.p.) at a
concentration of 2 μg per mouse in a 100 μl volume.

Additionally, THC or vehicle

(Ethanol) was administered in 3 doses. The first dose of THC (20mg/kg, i.p.) was given
immediately after first SEB exposure. Then, the second and third doses of THC (10mg/kg,
i.p.) were given after an additional 24h and 48h, respectively. SEB-exposed mice that
displayed signs of lethargy, hunching, ruffled fur and respiratory distress were humanely
euthanized. Mice were euthanized 72h post-SEB exposure for tissue collection.
4.3.2 Chemicals and Regents:
Staphylococcus enterotoxin B (SEB) was purchased from Toxin Technologies
(Sarasota, FL, USA). Delta-9-Tetrahydrocannabinol (THC) was procured from the
National Institute on Drug Abuse at the National Institutes of Health (Bethesda, MD,
USA). RPMI 1640 culture medium, L-glutamine, penicillin-streptomycin mixture, HEPES
buffer, fetal bovine serum, and phosphate buffered saline (PBS) were purchased from
Invitrogen Life Technologies (Carlsbad, CA, USA). RNeasy and miRNAeasy Mini kits,
miScript primer assays kit, and miScript SYBR Green PCR kits were purchased from
QIAGEN (Valencia, CA, USA). iScript and miScript cDNA synthesis kits were purchased
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from Bio-Rad (Madison, WI). Epicentre’s PCR premix F and Platinum Taq DNA
Polymerase kits were purchased from Invitrogen Life Technologies (Carlsbad, CA).
ELISA kits for IL-2, IL1β, CCL2, and CCL5 (ELISA MAXTM Standard SET Mouse)
were purchased from Biolegend. Seahorse XFp Glycolytic Rate Assay Kits and XFP Cell
Mito Stress Test Kits were purchased from Agilent Technologies (CA, USA).
4.3.3 Histopathology of lung tissues:
Lung tissues from mice were fixed in 4% paraformaldehyde solution, dehydrated in
alcohol, and embedded in paraffin. Microtome sections were cut to 5 µm thick, stained
with hematoxylin and eosin (H&E), and examined for inflammatory cell infiltrates under
Cytation 5 cell imaging multi-mode reader microscopy (Biotek).
4.3.4 Analysis of Cytokines:
Cytokine concentrations were measured in broncho-alveolar lavage fluid (BALF).
BALF was obtained from euthanized mice by binding the trachea with a suture and
excising the lung along with the trachea as described previously (102). Then, 1 ml of sterile,
ice-cold PBS was injected through the trachea to lavage the lungs. The aspirated BALF
was centrifuged to obtain supernatants containing cytokines. ELISAs were performed
using ELISA MAX™ standard kits from Biolegend, following the manufacturer protocols.
4.3.5 TUNEL assay:
Apoptosis was detected by Apo-Direct terminal deoxynucleotidyl transferase dUTP
nick end labeling (TUNEL) Assay Kit (Millipore Sigma, USA). Isolated lung mononuclear
cells were washed with PBS, fixed with 4% paraformaldehyde at room temperature for
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30m, and permeabilized with 0.2% TritonX 100 for 5m. TUNEL solution master mix was
added to each tube and incubated in a humidified incubator for 1h. Next, cells were washed
twice with PBS then analyzed by flow cytometry.
4.3.6 Mitochondrial membrane potential:
To analyze mitochondrial membrane potential, lung mononuclear cells were collected
and stained with DiOC6(3) dye (ENZO Life Sciences). The cells were incubated in dye
for 20m at 37OC, then washed twice with pre-warmed PBS and analyzed by flow
cytometry.
4.3.7 Purification of CD3+ T cells:
CD3+ T cells were purified from splenocytes, as described previously (8). In brief,
splenocytes were collected from mice and labeled with PE-conjugated anti-CD3 antibody
(BioLegend, Clone:17A2). Immunomagnetic selection was achieved by use of PE Positive
Selection Kit (STEMCELL Technologies).
4.3.8 Metabolic Assays:
Seahorse Mito Fuel Flex Test kit and cell mitochondrial stress test kit were used to
measure oxygen consumption rates (OCR) in CD3+ T cells according to the manufacturer’s
protocol (Agilent, Santa Clara, CA). Purified T cells were seeded in each well of an XFp
cell culture mini plate at a density of 2×105 cells/well. The XFp cell culture plates were
pre-coated with CellTak (Corning, NY) to allow the T cells to adhere to the bottom of
wells. Measurements were performed on a Seahorse XFp Analyzer (Agilent). Seahorse
Wave software was used to interpret acquired data and calculate OCR of purified T cells.
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4.3.9 Metabolomic Studies- Measurement of glycolysis, TCA and Tryptophan metabolites
using LC-MS:
4.3.9.1 Sample preparation for mass spectrometry and metabolomics analysis:
Metabolites were extracted from serum using the extraction procedure described
previously (176-181). Befely, 50 ul of serum sample was used for the metabolic extraction.
The extraction step started with the addition of 750 µL ice-cold methanol:water (4:1)
containing 20 µL spiked internal standards to each cell pellet or tissue sample. Ice-cold
chloroform and water were added in a 3:1 ratio for a final proportion of 1:4:3:1
water:methanol:chloroform:water. The organic (methanol and chloroform) and aqueous
layers were mixed, dried and resuspended with 50:50 methanol: water. The extract samples
were deproteinized, followed by resuspension and subjected to LC/MS analysis. 10 µL of
suspended samples was injected and analyzed using a 6490 triple quadrupole mass
spectrometer (Agilent Technologies, Santa Clara, CA) coupled to a HPLC system (Agilent
Technologies, Santa Clara, CA) via single reaction monitoring (SRM).
4.3.9.2 Separation of Tryptophan metabolites:
ESI positive mode was used to measure the poly amines. For the targeted profiling
(SRM), the RP chromatographic method employed a gradient containing water (solvent A)
and acetonitrile (ACN, solvent B, with both solvents containing 0.1% Formic acid).
Separation of metabolites was performed on a Zorbax Eclipse XDB-C18 column (50 × 4.6
mm i.d.; 1.8 μm, Agilent Technologies, CA) maintained at 37 C. The binary pump flow
rate was 0.2 ml/min with a gradient spanning 2% B to 95% B over a 25-minute time period.
Gradient: 0 min-2% B; 6 min- 2% of B, 6.5 min-30 % B, 7 min- 90% of B, 12 min 95% of
B,13 min 2% of B followed by re-equilibration at end of the gradient.
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4.3.9.3 Separation of Glycolysis, TCA and Pentose pathway metabolites:
Tri carboxylic acid cycle and Glycolysis cycle metabolites were identified by using
5mM ammonium acetate in water as buffer PH 9.9 (A) and 100% acetonitrile as buffer
(B) using Luna 3µM NH2 100 A0 Chromatography column (Phenomenex, Torrance,
CA).The Gradient: 0-20 min-80% B (Flow rate 0.2ml/min); 20-20.10 min- 80% to 2 % B;
20.10-25 min-2% B(Flow rate 0.3ml/min); 25-30 min 80% B (Flowrate 0.35ml/min); 3035 min-80%B (Flow rate 0.4ml/min); 35-38 min 80% B (Flow rate 0.4ml/min); followed
by re-equilibration at the end of the gradient to the initial starting condition 80% B at Flow
rate of 0.2 ml/min. All the identified metabolites were normalized by spiked internal
standard.
4.3.10 Single Cell RNA-seq and Analysis:
The TC20 Automated Cell Counter (BioRad) was utilized to measure the cell count
and viability of isolated lung cells. With a target of 1000 cells, we loaded them onto the
Chromium Controller (10x Genomics).

Following the manufacturer’s protocol, the

Chromium single cell 5′ reagent kits (10x Genomics) were used to process samples into
single cell RNA-seq (scRNAseq) libraries. Sequencing of those libraries was performed
using the NextSeq 550 instrument (Illumina) with a depth of 40k–60k reads per cell. The
base call files generated from sequencing the libraries were then processed in the 10x
Genomics Cell Ranger pipeline (version 2.0) to create FASTQ files. The FASTQ files were
then aligned to the mm10 mouse genome and the read count for each gene in each cell was
generated. Downstream analysis was completed using Seurat suite version 3.0 (Butler et
al., 2018, Stuart, Butler, et al., 2019) within R studio. Data were integrated in Seurat using
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anchor and integration functions. The integrated data was scaled and Principal-component
analysis (PCA) was completed for dimensionality reduction. Clusters were made following
PCA analysis by adjusting the granularity resolution to 0.25. We determined the number
of principal components (PCs) to utilize post JackStraw analysis within Seurat to determine
PCs with the lowest p-value. Differential expression was determined for each cluster to
determine cluster biomarkers, and between the disease and treated samples using the
default Wilcoxon rank sum test.
4.3.11 Quantitative Real-Time PCR (qRT-PCR) validation of selected miRs and associated
genes:
To validate the expression of selected miR-185 and associated genes (Bad, Bax, Cox4,
Runx3, Hrk and Nkiras2), qRT-PCR was performed in lung infiltrating MNCs isolated
from SEB+Veh or SEB+THC mice. In brief, total RNA from lung-infltrating MNCs was
isolated using miRNeasy kit from Qiagen and following the manufacturer's instructions.
miScript primer assays kit and miScript SYBR Green PCR kit from QIAGEN were used
and qRT-PCRs were performed following the protocol of the company (QIAGEN,
Valencia, CA). For qRT-PCR, 40 cycles using the following conditions: 15m at 95°C
(initial activation step), 15s at 94°C (denaturing temperature), 30s at 60°C (annealing
temperature), and 30s at 70°C (extension temperature and fluorescence data collection)
were used. SNORD96A was used as the housekeeping miR loading control. To determine
the expression of genes, GAPDH was used as the loading control. Significant differences
(p<0.05) in expression were determined by Student’s t test were determined with online
miRNA database (www.microrna.org). The sequences primers used are described in
Table1.
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4.3.12 Statistical analysis:
All statistical analyses were carried out using GraphPad Prism v8 Software (San
Diego, CA, USA). In all the experiments, the number of mice used was 5 per group, unless
otherwise specified. Student's t-test was used to compare the two groups, whereas multiple
comparisons were made using one-way ANOVA, followed by post hoc analysis using
Tukey's method. A p value of <0.05 was considered statistically significant. Individual
experiments were performed in triplicate. Each experiment was performed independently
at least three times to test the reproducibility of results. Metabolomic Studies analysis were
determined by log2-transformed and normalized with internal standards on a per-sample,
per-method basis. Statistical analyses were performed with either ANOVA or t-test in R
Studio (R Studio Inc., Boston, MA). Differential metabolites were identified by adjusting
the p-values for multiple testing at an FDR (Benjamini Hochberg method) threshold of
<0.25.
4.4 Results
4.4.1 THC treatment prevents SEB-induced pulmonary damage via reduction of infiltrating
immune cell:
It is well known that dual-dose SEB exposure in C3H mice is fatal due to massive
production of inflammatory cytokines and chemokines that lead to exponential
proliferation of effector T cells and other immune cell phenotypes (27) . In current study
we found that dual SEB exposure versus naïve mice resulted in massive infiltration of
immune cells in the lungs (Figure 4.1A). Interestingly, SEB+THC mice showed a
noticeable reduction in the abundance of infiltrating cells in the lung parenchyma when
compared to SEB+Veh mice (Figure 4.1A). Consequently, SEB+Veh mice in contrast to
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naïve mice had elevated levels of proinflammatory cytokines IL-1β and IL-2 in BALF,
while THC treatment led to significant reduction in these cytokines (Figure 4.1B). Similar
trends for the chemokines, CCL2 and CCL5 were also observed (Figure 4.1C). Then, in
order to determine whether the decrease in lung infiltration was due to induction of
apoptosis, we performed Tunel staining by flow cytometry. Our data showed that THC
induced apoptosis in lung infiltrating MNCs (Figure 4.1D). THC also led to a reduction in
mitochondrial membrane potential by DiOC(6)3 staining (Figure 4.1E) . To confirm our in
vivo results, we examined apoptosis in vitro. To this end, we activated naïve splenocytes
with SEB (1 μg/ml) for 72 hours in the presence of either 10uM THC or VEH. Cells were
then collected and stained with anti-CD3 and DiOC(6)3 and likewise, THC led to increased
apoptosis and loss of mitochondrial membrane potential in SEB-activated T cells (Figure
4.1F). Furthermore, we tested the direct effect of THC on the proliferative capacity of
immune cells in vitro by performing 3H-thymidine incorporation assay, specifically by
stimulating naïve splenocytes with SEB and then treating them with THC or Veh for 72
hours. As expected, SEB activation led to increased proliferation when compared to nonactivated T cells, while 10uM THC reduced SEB-induced proliferation (Figure 4.1G). We
further analyzed lung-infiltrating MNCs using mouse transcriptome arrays and found that
THC increased expression of genes related to apoptosis,

such as caspases (Casp1,

Casp14), release of mitochondrial cytochrome c including mitochondrial apoptogenic
protein 1 or cytochrome c oxidase assembly factor 8 (Apopt1 or Coa8) and Coa4, other
mitochondrial cytochrome c oxidases (Cox6a1, Cox7a1, Cox18), apoptosis-inducing factor
2-homologous mitochondrion-associated inducer of death (Aifm2) as well as autophagic
cell death comprising autophagy related 5 and 10 (Atg5 and Atg10) (Figure 4.1H). These
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studies suggested THC mediated induction of apoptosis and autophagic cell death by
altering cytochrome c oxidases of mitochondrial electron transport chain in MNCs
infiltrating the lung in SEB-induced ALI.
4.4.2 Pulmonary scRNAseq shows reduction of inflammatory components in SEB+THCtreated mice:
In order to elucidate the precise cells and the genes that may be altered in the lungs,
we performed scRNASeq. Whole lung tissue was collected from SEB-administered mice
treated with either THC or VEH and processed to single cell suspension for scRNASeq. tDistributed Stochastic Neighbor Embedding (t-SNE) plots showed that the distribution of
the major subpopulations of immune cells in ALI were alveolar macrophages, Mac1a and
Mac1b macrophages, neutrophils, CD4+ and CD8+ T lymphocytes, natural killer (NK) and
NKT cells (Figure 2A). The enrichment of these inflammatory populations was higher in
VEH-treated mice than in THC-treated mice (Figure 2B). Interestingly, scRNASeq
analysis showed increase in several genes in SEB+THC versus SEB+VEH groups, which
included mitochondria-associated apoptosis regulatory genes. This comprised elevated
expression of Bad in the CD4+ and CD8+ T cells, NKT cells as well as Mac1a and Mac1b
macrophages (Figure 4.2C), Bax in CD8+ T cells and NKT cells (Figure 4.2D), Cox4i1c
in CD4+ T cells, neutrophils, NK cells, B cells, alveolar and Mac1b macrophages (Figure
4.2E), Apopt1 in CD4+ and CD8+ T cells, NKT cells and NK cells (Figure 4.2F) as well
as Casp3 was elevated in CD4+ and CD8+ T cells, NKT cells, Mac1a and Mac1b
macrophages (Figure 4.2G) in SEB+THC treated group when compared to SEB+VEH
mice. Additionally, scRNASeq analysis showed that THC increased expression of genes
involved in metabolic reprogramming of immune cells, specifically genes encoding
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mitochondrial solute carrier family of proteins (Slc25) including a phosphate carrier
protein, Slc25a3 and an amino acid or iron carrier protein, Slc25a39 (Figure 4.2H).
4.4.3 THC-mediated amelioration of ALI is associated with altered T cell metabolism:
Given that THC induced apoptosis via the mitochondrial pathway and affected
mitochondrial solute transporter proteins, we next performed real-time cell metabolic
analysis of purified T cells. For this purpose, using Seahorse technology, we determined
the oxygen consumption rate (OCR) including first, the basal mitochondrial and nonmitochondrial respiration, and following addition of oligomycin, an ATP synthase
inhibitor, the ATP-linked respiration and proton leak. Next, we treated the cells with
FCCP, which mimics physiological stimulation of the respiratory chain causing oxidation
of all substrates including sugars, fats and amino acids to obtain maximal respiratory
capacity and finally we added Rotenone/Antimycin A, respiratory chain complex I and III
inhibitors respectively to determine reserve capacity. Our studies on OCR showed that T
cells from SEB+THC group had decreased basal respiration, proton leak, ATP-linked
respiration, maximal respiratory capacity and reserve capacity when compared to
SEB+VEH group (Figure 4.3A). We next estimated the dependency of these activated T
cells on glucose versus fatty acids as main substrates for their metabolic functions. In order
to determine the glucose dependency, we examined the OCR by blocking glucose oxidation
in presence of UK5099, an inhibitor of mitochondrial pyruvate carrier followed by
blocking of both fatty acid and glutamine oxidation using Etomoxir, a carnitine palmitoyl
transferase 1 inhibitor and BPTES, a glutaminase inhibitor. Furthermore, -oxidation
dependency was studied by examining OCR in the presence of etomoxir that blocks fatty
acid metabolism, followed by treatment of the cells with BPTES and UK5099 that block
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both amino acid and glucose oxidation. Interestingly, we found that while the OCR was
decreased significantly in SEB+VEH cells, the metabolic activity of THC-treated T cells
was independent of glucose utilization (Figure 4.3B). However, these THC-treated T cells
exhibited trended towards being dependent on the β-oxidation pathway to fulfill energy
demands (Figure 4.3C).
4.4.4 Metabolomic Profiling:
Moreover, metabolomic profile of serum showed that SEB+THC mice had elevated
levels of carnitine pathway metabolites that are displayed in a heat map (Figure 4.3D) when
compared to SEB+VEH group. Specifically, metabolomic analysis showed significant
increase in the serum concentrations of propionyl-L-carnitine (PLC) (Figure 4.3E), free
carnitine (Figure 4.3F), lysine (Figure 4.3G), and n-acetyl methionine (Figure 4.3H) in
SEB+THC mice, indicating that there was dysregulation in carnitine metabolism pathway
following SEB-exposure. Carnitine is made from the amino acids, lysine and methionine.
Carnitine transports long chain fatty acids from cytosol to mitochondrial matrix and is
therefore important for -oxidation. Carnitine can be converted to PLC. Interestingly, PLC
has been shown to promote induction of apoptosis (79) . To test if the effect of THC on
metabolism may be contributing to increased cell death in infiltrating immune cells, we
activated naïve splenocytes with SEB (1 μg/ml) for 72 hours in the presence of PLC
(200 μM). The data showed that PLC-treated cells had reduced mitochondrial membrane
potential and increased apoptosis (Figure 4.3I). Next, 3H-thymidine incorporation assay
confirmed that PLC had no significant effect on proliferation of naïve splenocytes (Figure
4.3J). However, addition of PLC to culture medium led to significant suppression of
proliferation in SEB-activated splenocytes (Figure 4.3J).
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4.4.5 THC-mediated apoptosis of SEB-activated T cells is epigenetically regulated:
We performed miR microarray and found a number of dysregulated miRs in these two
groups of mice. Ingenuity pathway analysis (IPA) was used to predict most common
pathways involved in modulating immune cell metabolism and proliferation capacity of
lung infiltrating MNCs. We found that down-regulation of miR-185-3p in SEB+THC
versus SEB+VEH mice. This miR-185-3p promoted apoptosis induction and inhibited
NFkB signaling (Figure 4.4A). Next, we validated the downregulation of miR-185
expression in lung infiltrating MNCs in SEB+THC in SEB+VEH group using qRT-PCR
(Figure 4.4C). To confirm alignment existence between miR-185 and 3’UTR region of
target genes, microRNA.org was used (Figure 4.4D). Furthermore, qRT-PCR validated
upregulation of miR-185 target genes that regulate apoptosis including Bad (Figure 4.4E),
Bax (Figure4. 4F), Runx3 (Figure 4.4G), Cox4 (Figure 4.4H), and Hrk (Figure 4.4I). Also,
we found NKIRAS2, encoding an inhibitor of NF-ĸB signaling, was elevated in SEB+THC
versus SEB+Veh (Figure 4.4J).
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4.5 Discussion
ALI is a disorder caused by acute pulmonary inflammation resulting in lung epithelial
and endothelial cell damage.

ALI can lead to acute respiratory distress syndrome

characterized by high mortality rates of 36–44% (38).

There are no effective

pharmacological therapies for ALI as treatment only involves general supportive measures
necessary for the critically ill, combined with focused ventilator strategies. Risk factors
which associate with development ALI could be genetic predisposition, obesity, chronic
alcohol abuse, and chronic liver disease (182-185). Approximately 34% of ALI patients
survive, however many survivors experience poor quality of life, depression, anxiety, and
post-traumatic stress disorder (PTSD) (36, 186-188). SEB is one of the most important
toxin threats in bioterrorism and is listed as a biological-warfare agent, which the Centers
for Disease Control (CDC) has classified as a category B priority agent (26). Investigation
from our lab found that SEB inhalation caused vascular leak, massive infiltration of
lymphocytes, and cell death in the endothelial cells of the terminal vessels of the lung
during ALI (30).
Cannabis is the marijuana plant that has more than 113 compounds called
cannabinoids. THC is generally the most abundant cannabinoid found in Cannabis extracts
(1). THC is also the main psychoactive compound in marijuana, but is known to have antiinflammatory properties, and can induce apoptosis and autophagy (22, 113, 171). In the
current study, we found that treatment with THC after exposure to SEB can induce
apoptosis in activated immune cells in the SEB-mediated ALI model.
In a recent study, we found that THC can reduce the inflammation in the lung by
decreasing the infiltrating immune cells, edema, and congestion which are markers for
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ALI (35). Furthermore, THC decreased pro inflammatory cytokines IL-2 and IL1β, which
are the most important cytokines that lead to toxic shock syndrome (27). We also found
reduction in CCL2 and CCL5, which are chemokines that recruit leukocytes including T
cells such as memory T cells, and monocytes (189, 190). In the current study, we observed
that THC can induce apoptosis in the MNCs of the lung by the intrinsic pathway. TUNEL
staining which depends on terminal deoxynucleotidyl transferase (TdT)-mediated dUTP
nick-end labeling to detect apoptotic DNA fragmentation was increased significantly after
THC treatment (191-193). DiOC6(3) is a cationic dye, which strongly labels mitochondria.
Loss of mitochondrial membrane potential (MMP) is among the changes during early
stages of apoptosis and a decrease in MMP in apoptotic cells is associated with a reduction
in the expression of DiOC6(3), which we observed after THC treatment (194, 195).
Additionally, 3H-thymidine incorporation assay is still the most commonly employed
proliferation assay because of its sensitivity and relative reliability to quantify cellular
proliferation (196). The dose-dependent decrease in activated T cell proliferation in THCexposed cells was consistent with its ability to induce apoptosis.
In the current study, we sought to identify dysregulated genes by examining the
transcriptome in MNCs from the lungs in SEB+VEH and SEB+THC groups. Interestingly,
we found that genes associated with mitochondrial functions such as Mitochondrial
Apoptogenic Protein 1 (Apopt1), also known as cytochrome c oxidase assembly factor 8
(Coa8) and Coa4, as well as mitochondrial cytochrome c oxidases (Cox6a1, Cox7a1,
Cox18) and Apoptosis-inducing factor 2-homologous mitochondrion-associated inducer of
death (Aifm2) were upregulated in lung-infiltrating MNCs following THC treatment in
SEB-induced ALI. These genes encode for proteins that localize in the mitochondria where
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they stimulate the release of cytochrome c and consequently induce apoptosis. Coa genes
encode for proteins that are required for the assembly of the terminal cytochrome c complex
IV or cytochrome c oxidase of the mitochondrial respiratory chain that transports electrons
to molecular oxygen and contributes to ATP synthesis (197). In addition, autophagy
related 5 and 10 (Atg5 and Atg10) were also upregulated following THC treatment.
Inasmuch as, autophagy is a process of removal of damaged organelles and misfolded or
aggregated proteins, it plays a critical role in preventing inflammatory diseases (198).
Specifically, it has been demonstrated that naïve T cells exiting from the thymus depend
on autophagy-related mitochondrial content reduction (199). Furthermore, loss of ATG5
in T cells was shown to result in an inflammatory response and loss of tolerance (199).
Indeed, the reduction in expression of Atg genes observed in SEB+VEH group may be a
factor in induction of inflammatory response. These studies suggested THC-mediated
involvement in apoptosis, autophagy and importantly, cytochrome c oxidases of
mitochondrial electron transport chain in mononuclear cells infiltrating the lung following
SEB-induced ALI.
In order to detect genes involved in THC-induced apoptosis in various immune cell
subpopulations, we performed scRNASeq. The mitochondrial pathway of apoptosis is
influenced by Bcl family members bound to the mitochondrial membrane, including both
the anti-apoptotic members, Bcl-2 and Bcl-xL as well as the pro-apoptotic regulatory
proteins, Bax and Bak which can induce apoptosis by forming a pore in the mitochondrial
outer membrane for the release of cytochrome c and other pro-apoptotic factors to the
cytosol (200). In contrast, Bad heterodimerizes with the anti-apoptotic regulatory protein
Bcl-2 and inactivates it, thereby allowing Bax/Bak to induce apoptosis. In the cytoplasm,
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cytochrome c along with adenosine triphosphate (ATP) binds to apoptosis protease
activating factor-1 (APAF-1) to form a multimeric complex that recruits and activates procaspase-9 to caspase 9 which in turn activates caspase 3 and induces apoptosis. Caspase3 gene was elevated in CD4+ and CD+ T cells from SEB+THC group which regulates the
inhibition of DNA repair and starts DNA degradation (168).

It should be noted that

mitochondrial cytochrome c and cytochrome c oxidase subunit IV (COX IV) productivity
are early events in progress of apoptosis onset (201). Furthermore, Apopt1 which was
elevated in SEB+THC when compared to SEB+Veh, has also been shown to induce
apoptosis independent of Bax/Bak pore formation (202).
Our studies also found that THC caused alteration in T cell metabolism. Metabolic
analysis of SEB+THC versus SEB+VEH T cells detected a reduction of mitochondrial
respiration, specifically in basal respiration, maximal respiratory capacity, proton leak and
spare respiratory capacity, while increasing the dependence on fatty acid metabolism in the
former. This observation indicates that THC stunts cell growth based on a previous study
which showed that T cell growth and function requires rapid increases in glycolysis and
decrease in lipid metabolism (203). During activation, T cells undergo metabolic
reprogramming which is believed to be critical for cells to sustain the biosynthesis of lipids,
proteins and nucleic acids required for cell proliferation, therefore, increase in glycolysis
is observed in effector and activated T cells (204).
We also found that THC caused alterations in serum metabolome, specifically
elevation in lysine, N-acetyl methionine, carnitine, and propionyl carnitine (PLC). Lysine
and methionine are precursors of carnitine, which is found in animal proteins that plays an
important role in fat metabolism by transporting long chain fatty acids from cytosol to
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mitochondrial matrix, and therefore useful in -oxidation of fatty acids. L-carnitine has
been used in the treatment of cardiovascular, end-stage renal and other diseases (205) . Nacetyl-L-methionine is similar to L-methionine both nutritionally and metabolically (206).
It is used as a dietary supplement. Methionine is an essential amino acid required for
normal development in humans.

Methionine deficiency leads to decrease in liver

functions. It is also required for cysteine synthesis. While methionine is required for
angiogenesis, high levels may lead to increase in homocysteine which is an indicator of
cardiovascular disease (207). The presence of excess methionine may also lead to DNA
methylation and induction of cancer (207).
Propionyl-L-Carnitine is a naturally occurring amino acid, derived from L-carnitine.
PLC is used in the treatment of heart failure and peripheral vascular disease. Importantly,
PLC can induce apoptosis through the intrinsic pathway via activation of Bax gene (79).
Our results were consistent with this observation, inasmuch as, addition of PLC triggered
apoptosis and decreased cell proliferation.
We have reported previously that THC treatment following SEB injection alters the
expression of miRs in lung-infiltrating immune cells (100) . In this study, we focused on
miR-185 which was found to be downregulated by THC in lung-infiltrating MNCs of mice
exposed to SEB, when compared to mice treated with vehicle. Upon pathway analysis of
miRs using IPA, we identified miR-185 in MNCs may play a significant role in THCinduced immune suppression via induction of apoptotic genes Bad, Bax, Hrk, and Apopt1.
miR-185 plays an essential role in in various diseases, for instance, tumor suppression in
nasopharyngeal carcinoma, and also inhibits invasion, migration and proliferation of
squamous cell carcinoma (208) (209) . Furthermore, miR-185 can be therapeutic target for
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gastric cancer because it can induce apoptosis via activation of Runx3 gene (210).
Inhibition of miR-185 caused PTEN induction and AKT inhibition, thus promoting
apoptosis (211). miR-185 can also induce apoptosis in lung epithelial cells and decrease
in cell proliferation during hypoxia (212). Together, our data indicate that THC may
mediate beneficial effects on ALI by promoting immune cell apoptosis via downregulation
of miR-185-3p.
In summary, the current study suggests that treatment of mice with THC post-SEB
challenge protects mice from SEB-mediated toxicity by inhibiting inflammation and ALI
through the modulation of miRs targeting mitochondria-related apoptotic genes. Because
SEB is a superantigen that drives cytokine storm, our studies suggest that THC is a potent
anti-inflammatory agent that has the potential to be used as a therapeutic modality to treat
SEB-induced ALI.

Importantly, the metabolomic and metabolic profiling indicate

profound effects on mitochondrial functions that may be responsible for anti-inflammatory
activity of THC. This study also suggests that THC may mediate its effects through
downregulating the expression of miR-185-3p and consequent upregulation of apoptotic
genes and pathways, and thus, targeting miR-185-3p, may constitute another therapeutic
modality for alleviation of ALI.
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Figure 4.1: THC attenuates SEB-induced acute lung injury (ALI) in mice via induction of
apoptosis. SEB was administered first by the intranasal (i.n.) route followed by a second
dose of SEB was delivered (i.p.) as described in Methods. Mice were then treated with
vehicle (SEB+Veh) or THC (SEB+THC).
A: Showing Representative images of
histopathological H&E staining sections of excised lung tissues. B-C: Enzyme-linked
immunosorbent assay (ELISA) was used in the measurement of serum cytokines and
chemokines. D: Mononuclear Cells from lung were stained for CD3 analyzed for apoptosis
based on terminal deoxynucleotidyl transferase–mediated digoxigenin-deoxyuridine nickend labeling (TUNEL). E: Mononuclear Cells from lung were stained for CD3 analyzed
for apoptosis based on DiOC6 (3) (3, 3’-Dihexyloxacarbocyanine Iodide). F: Splenocytes
from C3H/HeJ mice were activated with SEB (1 μg/ml) in the presence of either vehicle
or THC 10 μM for 72 hours. Cells were stained for CD3 analyzed for apoptosis based on
DiOC6 (3) (3, 3’-Dihexyloxacarbocyanine Iodide). G: Splenocytes from C3H/Hej mice
were activated with SEB (1 μg/ml) in the presence of either vehicle or THC (5, 10 μM) for
72 hours. T cell proliferation was measured by [3H]-thymidine incorporation (CPM, counts
per minute). H: MNCs from the lungs were isolated and subjected to transcriptional
analysis as described in Methods. Heat map showing genes associated with apoptosis in
SEB+vehicle vs SEB+THC groups. Vertical bars show data from 4 mice with Mean+/SEM. Statistical significance is depicted as * P<0.05, ** P<0.01, *** P<0.001 between
the groups.
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Figure 4.2: Single cell RNA sequencing of lung cells reveals the genes associated with
apoptosis pathway in THC and vehicle treated mice. Mice were treated with SEB+Veh or
SEB+THC as described in Fig 1 legend. Panels A: ScRNAseq tSNE colored by cell type.
B: ScRNAseq tSNE Split by sample ID and colored by cell type. C: Violin plots Bad
expression amongst the clusters in SEB+Veh vs SEB+THC. D: Violin plots Bax
expression amongst the clusters in SEB+Veh vs SEB+THC. E: Violin plots Cox4
expression amongst the clusters in SEB+Veh vs SEB+THC. F: Violin plots Apopt1
expression amongst the clusters in SEB+Veh vs SEB+THC. G: Violin plots Casp3
expression amongst the clusters in SEB+Veh vs SEB+THC. H: Violin plots Solute carrier
gene Slc25a3ans Slc25a39 expression amongst the clusters in SEB+Veh vs SEB+THC
Statistical significances are depicted as * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001
between the groups.
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Figure 4.3: THC treatment decreases T cells activation and alter body metabolites to
attenuate acute lung injury and induce apoptosis. Spleen cells were cultured with
SEB+THC or SEB+Veh for 72 hours then CD3 T cells were purified as described in
Methods. A: shows oxygen consumption rate in cells mitochondrial stress test. B: shows
oxygen consumption rate in glucose oxidation dependency test. C: shows oxygen
consumption rate in β-oxidation dependency test. Panels show data from 4 mice with
Mean+/-SEM. D: Heat map showing metabolome in serum associated with apoptosis in
SEB+vehicle vs SEB+THC group. E-H: molecule of metabolites in serum from
SEB+vehicle vs SEB+THC group. I: Splenocytes from C3H/HeJ mice were activated with
SEB (1 μg/ml) in the presence of either vehicle or propionyl-L-carnitine 200 μM for 72
hours. Cells were stained for CD3 analyzed for apoptosis based on DiOC6 (3) (3, 3’Dihexyloxacarbocyanine Iodide). J: Splenocytes from C3H/Hej mice were activated with
SEB (1 μg/ml) in the presence of either vehicle or propionyl-L- carnitine 200 μM for 72
hours. T cell proliferation was measured by [3H]-thymidine incorporation (CPM, counts
per minute). Statistical significances are depicted as * P<0.05, ** P<0.01, *** P<0.001,
**** P<0.0001 between the groups.
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Figure 4.4: THC alters miR expression in lung infiltrated MNCs exposed to SEB. Mice
were treated with SEB+Veh or SEB+THC as described in Fig 1 legend. MNCs from the
lungs were isolated and screened for miR expression. A: Shows pathways and relationship
between miRs and genes post IPA analysis of dysregulated miRs. B: Showing binding
affinity between miR-185-3p and Bad, Hrk, Runx3, Cox4 and Nkiras2. C: THC suppressed
the expression of miR-185-3p in lung infiltrated of mice exposed to SEB and treated with
vehicle or THC. D-I Increasing in the expression of targeted genes Bad (D), Bax (E), Hrk
(F), Runx3 (G), Cox4 (H), and Nkiras2 (I) in lung infiltrated MNCs post exposure to SEB
and treated with THC, when compared to SEB+Vehicle group. Statistical significances
are depicted as * P<0.05, ** P<0.01, *** P<0.001, **** P<0.0001 between the compared
groups.
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Table 4.1 Primer sequences

Forward Primer (5’→3’)

Reverse Primer (5’→3’)

CAGGTTCAACGACCTTCGAT

GTGGTAGGTAGCCACTTGGG

Gene name
Runx3

T
Nkiras2

TCTGTGGGCAAAACTTCAAT

CGATGGAGCCTACATAGATG

CC

TCC

Bad

AAGTCCGATCCCGGAATCC

GCTCACTCGGCTCAAACTCT

Bax

TGAAGACAGGGGCCTTTTTG

AATTCGCCGGAGACACTCG

Cox4

CTCTTCGTGGACTGCATCCC

GGTAATAGCCAGCGATCAC
ATAG

Hrk

CAAAGCCTGGGAGGTCTGA

TCTCACAAAGGCTTCGGTCC

G
FoxP3

CCCATCCCCAGGAGTCTTG

ACCATGACTAGGGGCACTGT
A

IL-10

GCTCTTACTGACTGGCATGA

CGCAGCTCTAGGAGCATGTG

G
NOS2

TGF- βR2

TTCAGATCCCGAAACGCTAC

ACAATCCACAACTCGCTCCA

AC

AG

GGAGAAGTGAAGGATTACG

CACACGATCTGGATGCCC

AGC
GAPDH

AGGTCGGTGTGAACGGATTT

TGTAGACCATGTAGTTGAGG

G

TCA

95

CSF1R

NOS1

CTTCAGCATCTTCACAGCCA

AGAGCTATGAGGGCAACAG

CCTT

TT

AAAACACCCTTGTTACCACA

AGCTCTTGTCCGTACCAC

C
SOCS1

ACAAGCTGCTACAACCAGG

ACTTCTGGCTGGAGACCTCA

G
Lysozyme1

GAGACCGAAGCACCGACTA

CGGTTTTGACATTGTGTTCG

TG
Lysozyme2

ATGGAATGGCTGGCTACTAT
GG

Defensin beta
1 (Defb1)

AGGTGTTGGCATTCTCACAA
G

ACCAGTATCGGCTATTGATC
TGA
GCTTATCTGGTTTACAGGTT
CCC

Defb2

TCCTGGTTGACGAGACCACA

AGGCATTTCTGCATAACCCC
T

Mucin 2

TCCAGGTCTCGACATTAGCA

GTGCTGAGAGTTTGCGTGTC
T

(Muc2),

G

Muc5b

GTGGCCTTGCTCATGGTGT

GGACGAAGGTGACATGCCT

Claudin 18

ATGGGCTTAGTCTTCCGAAC

CTTCCAGTGCGGCAAGTAGT
T

G
ZO- 1

CTCCAGAGCACCGAGAGCT
A

Occludin

TTGAAAGTCCACCTCCTTAC
AGA
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GGCGTTTGCGAAGTTCTTCA
T
CCGGATAAAAAGAGTACGC
TGG
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